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Embryonic stem cells (ESCs) represent a unique cell population that can differentiate 
into all three embryonic germ layers-endoderm, mesoderm, and ectoderm, rendering 
them an invaluable cell source for studying the molecular mechanisms of embryonic 
morphogenesis. Signaling molecules that direct tissue patterning during embryonic 
development are secreted by ESC aggregates, known as embryoid bodies (EBs), which 
emulate aspects of embryonic morphogenesis. ESCs within EBs spontaneously 
differentiate during in vitro culture synthesizing a complex array of various factors and 
soluble cues that direct cell fate. Furthermore, EB models provide an attractive in vitro 
platform from which cells of specific developmental stages, including vasculogenesis, 
can be enriched and analyzed for morphogen expression. Strategies to direct 
differentiation of EBs often employ an “outside-in” approach by addition of soluble 
factors to culture medium. However, diffusion of soluble factors into EBs is limited due to 
formation of dense outer cell layer, resulting in nonhomogenous differentiation. One 
method to direct differentiation and potentially overcome diffusion limitations is via 
incorporation of engineered microparticles (MPs), within 3D multicellular aggregates. 
Extracellular matrix (ECM) components, such as glycosaminoglycans (GAGs), play 
crucial roles in cell signaling and regulation of morphogen gradients during early 
embryonic development through binding and concentration of secreted growth factors, 
thus directing patterns of tissue morphogenesis. ECM-mimetic materials or engineered 
MPs amenable to conjugation of highly sulfated GAGs, such as heparin, provide ideal 
matrices for manipulation of ESC morphogens via reversible electrostatic and affinity 
interactions. The long term goal of this work was to develop a novel biomaterial based 
approach to direct ESC differentiation and identify important molecules in stem cell 




extracellular matrix can modulate ESC differentiation through sequestration of 
endogenous morphogens present within the EB microenvironment. 
Synthetic N-isopropylmethacrylamide (NIPMAm) MP constructs were 
investigated as a biomaterial-based strategy to control the temporal release of BMP4 
within ESC aggregates to induce mesoderm differentiation. pNIPMAm microgels were 
coupled to core polystyrene particles to combine the hydrophilic and morphogen-
releasing properties of hydrogels with a dense core material that enhanced incorporation 
within EBs.  MP synthesis produced well-coated population of MPs in terms of microgel 
coverage and low polydispersity. However, MPs incorporated with low efficiency within 
ESC aggregates. MP delivery of BMP4 within ESC aggregates demonstrated similar 
expression of mesoderm (Flk1) as compared to soluble BMP4 delivery, while ectoderm 
expression (Pax6) was significantly decreased as compared to soluble delivery. In 
addition, sentinel cells were used to monitor the spatiotemporal activation of BMP 
signaling in ESC aggregates, where maximum reported (CFP) expression was observed 
at day 2 of culture, coinciding with the burst release of BMP4 from MPs. Interestingly, 
ESC aggregates treated with unloaded MPs and soluble BMP4 demonstrated greater 
CFP expression over soluble BM4 treated aggregates, suggesting that unloaded MPs 
may bind and concentrate exogenously added BMP4 within aggregates to induce BMP 
signaling. Notably, the total amount of BMP4 delivered by MP was 10-fold less total 
growth factor as compared to soluble delivery to achieve comparable ESC 
differentiation, indicating that MP approaches can improve efficiency of differentiation, by 
reducing over delivery of soluble growth factor. 
Given that native GAGs modulate important ESC signaling pathways, 
supplementation (or incorporation) of heparin may enable strategies to manipulate 
endogenous cell signaling. Heparin-derived MPs can thus serve as a biomimetic 




that mimic the ECM in its ability to actively sequester proteins present in cell culture or in 
vivo, as opposed to delivery of bound proteins via biomaterials, introduces a new 
paradigm to harness native sequestering interactions between cells and ECM. 
Incorporation of HMAm MPs within EBs demonstrated the native ability of natural GAG-
based materials to modulate ESC differentiation. Incorporation of HMAm MPs within 
ESC aggregates demonstrated changes in gene and protein expression of 
neuorectodermal marker, Pax6. Histological analysis of aggregates with incorporated 
HMAm MPs exhibited more internal organized structures as observed via histolgical 
staining and more abundant protein expression for Nestin, a marker of neural precursor 
cells, as compared to untreated aggregates. It was also demonstrated that HMAm MPs 
can be used as a tool to sequester and concentrate biomolecules present in ESC 
conditioned media, while simultaneously reducing the amount of abundant species, such 
as bovine serum albumin (BSA), for gel electrophoresis and mass spectrometry 
analysis. Notably, MPs demonstrated approximately 20x less BSA binding,  
Furthermore, comparison of HMAm MPs with other GAG-based MPs exhibited different 
binding capacities for complex mixtures of proteins present in conditioned media, 
suggesting that MPs composed of different ECM components could be formulated to 
direct ESCs toward specific lineages. Ultimately, biomaterials capable of capturing 
morphogens in a reversible and concentrated manner similar to native GAG species will 










Embryonic stem cells (ESCs) are a unique cell population that can differentiate 
into all three embryonic germ layers (endoderm, mesoderm, and ectoderm), rendering 
them an invaluable cell source for studying the molecular mechanisms of embryonic 
morphogenesis. Signaling molecules that direct tissue patterning during embryonic 
development are secreted by ESC aggregates, known as embryoid bodies (EBs), which 
emulate aspects of morphogenesis observed during embryonic development. As many 
of these signaling proteins interact with the extracellular matrix (ECM), manipulation of 
the ESC extracellular environment provides a means to direct stem cell differentiation. 
Extracellular matrix (ECM) components, such as glycosaminoglycans (GAGs), play 
crucial roles in cell signaling and regulation of morphogen gradients during early 
development through binding and concentration of secreted growth factors. Engineered 
biomaterials fabricated from highly sulfated GAGs, such as heparin, provide ideal 
matrices for manipulation and efficient capture of ESC morphogens via reversible 
electrostatic and affinity interactions. In particular, heparin can simultaneously bind and 
influence the activity of multiple factors (FGF, BMP, VEGF etc). Thus, biomaterials 
designed to efficiently capture and retain bioactive ESC-derived morphogens offer 
an attractive platform to enhance the differentiation of ESCs toward defined cell 
types. The long term goal of this work was to develop a novel biomaterial based 
approach to direct ESC differentiation and identify important molecules in stem cell 
signaling. The overall objective of this work was to examine the ability of microparticles 




presentation of morphogens to direct ESC differentiation. The overall hypothesis of this 
work was that microparticles that mimic the ECM can modulate ESC differentiation 
through sequestration of morphogens present within the EB microenvironment. The 
rationale for this work is that ECM-mimetic biomaterials can capture morphogens in a 
reversible and concentrated manner similar to native ECM species in vivo, thereby 
enabling strategies to define and examine ESC morphogens produced during 
differentiation.  The central hypothesis of this proposal will be tested by the following 
specific aims: 
 
Specific Aim 1: Evaluate the use of synthetic ECM-mimetic MPs for directed 
differentiation of ESCs within EBs. The working hypothesis was that engineered 
synthetic MPs that mimic the ability of the native ECM to sequester and release BMP4 
within EBs will enhance the efficiency of ESC differentiation as compared to soluble 
delivery. BMP4 loading and release from MPs will be assessed as well as the efficiency 
of MP incorporation within EBs. Mesoderm differentiation of ESCs will be assessed by 
gene expression of markers of pluripotency (Oct4 and Nanog) and mesoderm 
(BrachyuryT and Flk1). Analysis of BMP signaling in ESCs in response to BMP will 
examined. 
 
Specific Aim 2A: Evaluate the incorporation of heparin-based microparticles on 
ESC lineage differentiation. The working hypothesis was that incorporation of heparin 
MPs would enhance neuroectodermal differentiation of EBs. MP incorporation in EBs 
was performed by forced aggregation of ESCs and MPs at various cell to MP ratios. The 
impact of MP incorporation on cell morphology was assessed by histological staining 
(H&E, Safrinin-O, and Alcian Blue) and EB plating for presence of neurite outgrowth and 




and Nestin) as well as markers of mesoderm (Flk1 and BrachyuryT) and endoderm 
(AFP) were assessed by PCR and immunostaining.  
 
Specific Aim 2B:  Characterize the profile of ESC morphogens captured by 
heparin MPs using gel electrophoresis and mass spectrometry analysis. The 
working hypothesis was that heparin MPs could be used to enrich for specific groups of 
morphogens secreted by differentiating ESCs. MPs were separated from dissociated 
embryoid bodies by density gradient centrifugation using a Percoll gradient. MP captured 
morphogens were analyzed by SDS-PAGE and mass spectrometry in order to 
characterize the classes of molecules presented by heparin MPs to ESCs during 
differentiation.  
 
This proposal is innovative because it harnesses the native ability of ECM-
based materials to sequester endogenous growth factors present within the EB 
microenvironment to drive ESC differentiation. Additionally, heparin-based materials can 
be used as an analytical tool to identify molecular factors involved in stem cell signaling. 
Ultimately, this proposal aims to develop a new class of biomaterials capable of 
capturing stem cell derived morphogens in a biomimetic manner to yield more efficient 
approaches for directed stem cell differentiation. It is anticipated that the results of this 
work will demonstrate the utility of an ECM mimetic biomaterial approach to harness the 
endogenous growth factors produced during ESC differentiation and ultimately 











2.1 Embryonic stem cells 
Embryonic stem cells (ESCs) have a unique regenerative capacity due to their 
ability to both self-renew and differentiate into a multitude of cells from various lineages, 
thus providing a promising avenue for tissue engineering and regenerative medicine 
therapies for treatment of cancer, diabetes, degenerative disorders and traumatic 
injuries. For instance, differentiation of ESCs toward cardiomyocytes [1–5], neurons [6–
9], endothelial cells [10–12], and pancreatic β-cells [13–16] has already been achieved.  
ESCs were derived from the inner cell mass of mouse blastocysts and are capable of 
differentiating into all three embryonic germ layers - endoderm, mesoderm, and 
ectoderm, as well as germ cells  [17,18].  Unlike adult stem cell populations, which are 
multipotent and limited in their ability to differentiate towards specific cell types, ESCs 
retain pluripotency through the process of self-renewal, rendering them an invaluable 
source for studying the molecular mechanisms of embryonic morphogenesis and cell 
fate decisions.  Typical differentiation strategies require specific media formulations, 
requiring addition of cocktails of small molecules or supraphysiological doses of 
biomolecules. However, the plasticity of ESCs also makes the generation of defined cell 
types difficult, thus motivating the need for differentiation strategies that enhance the 







2.2 ESC differentiation 
During embryonic development, gastrulation is characterized by the formation of 
the three germ layers. More specifically, epiblast cells mobilize to the primitive streak 
(PS) where they subsequently undergo epithelial-to-mesenchymal (EMT) transition to 
generate mesoderm and definitive endoderm [19,20]. Although the regulation of cell 
fates observed during gastrulation are not fully understood, the spatiotemporal 
separation of various cell types in the PS suggest the presence of different signaling 
cues that direct stem cell differentiation. Previous studies have established that 
morphogenic factors from the transforming growth factor (TGFβ) [21], Nodal [22], and 
Wnt [23] family are essential for germ layer development. 
Hematopoietic, cardiac, skeletal muscle and vascular lineages are derived from 
mesoderm supopulations during embryonic development. Following the formation of a 
PS-like population, early mesoderm is defined by the expression of brachyuryT, 
following upregulation of cell surface receptors, Flk1 and PDGFR [24,25]. In the absence 
of serum in cell culture, mesoderm formation is induced with supplementation of soluble 
BMP4 [26–28]. Furthermore, addition of Wnt to cell cultures with serum supplementation 
accelerates mesoderm development, while inhibition of Wnt blocks generation of 
brachyuryT expressing cells [29–31]. Nodal signaling is activated by addition of Activin 
A, inducing formation of mesoderm or endoderm populations [32].  In contrast, derivation 
of neural and skin lineages from ectoderm is induced by inhibition of BMP, Wnt, and 
Activin/Nodal signaling [32,33]. Characterized as the “default” pathway, neuroectoderm 
readily develops in the absence of serum or other PS inducers, and instead relies on 
endogenous FGF signaling [33]. Overall, these observations clearly indicate an 
important role for these signaling pathways in ESC differentiation and that manipulation 




2.3  Embryoid body differentiation 
Differentiation of ESCs is commonly performed in monolayer, providing a defined 
substrate for cell attachment and uniform exposure to exogenously added soluble 
molecules, such as growth factors or small molecules; however, 3D approaches allow 
for a biological model of embryonic morphogenesis by facilitating multicellular 
interactions [34]. The 3D organization and proliferation, migration, and differentiation of 
an embryo can be modeled by the formation of pluripotent stem cell aggregates, known 
as embryoid bodies (EBs) [35]. EB formation has traditionally been used to induce 
spontaneous differentiation of ESCs towards the three germ lineages. Differentiation of 
EBs is characterized by the initial formation of two epithelial layers, with the specification 
of exterior cells toward primitive endoderm (PE), mediated by fibroblast growth factor 
(FGF) signaling via the PI 3-kinase pathway [36,37].  The PE layer eventually 
differentiates to form visceral and parietal endoderm, while cells at the exterior deposit a 
basement membrane composed of ECM components including type IV collagen and 
laminin [37,38]. The basement membrane serves to separate the PE layer from the 
internal undifferentiated cell population, where cells not in direct contact with the 
basement membrane may undergo apoptosis to form cystic cavities [39,40].  
Culture platforms for EB formation include static suspension, hanging drop and 
forced aggregation [41]. Spontaneous formation of EBs is initiated by suspension of 
ESCs in a non-adhesive culture dish in the absence mouse embryonic fibroblasts 
(MEFs) feeder layers and/or Leukemia inhibitory factor (LIF). Dissociated ESCs are 
transferred to suspension cultures and allowed to aggregate to form 3-dimensional 
structures through the homophilic binding of the cell-cell adhesion molecule E-cadherin, 
which is highly expressed on the cell surface of undifferentiated ESCs [41,42]. However, 
static suspension of EBs often results in a heterogeneous population due to variable 




More controlled EB formation can be accomplished by the hanging drop method, which 
involves the suspension of a relatively small number of cells within a single drop (10-20 
μL) from the lid of a Petri dish [2]. While allowing for greater control of EB size, the 
hanging drop technique is labor-intensive and not amenable to scale up for 
bioprocessing applications. Alternatively, formation of EBs by rotary suspension culture 
has demonstrated improved aggregate formation, cell yield and homogeneity within the 
population [43]. Furthermore, high throughput culture formats have also been developed 
to improve uniform EB formation, such as AggreWellTM technology[44], dielectrophoresis 
[45], and bioprinting [46,47]. Ultimately, 3-dimensional culture of ESCs reduces the 
surface area required for cell culture, allowing for the scale up of culture systems for 
bioprocessing platforms, and ultimately generating larger quantities of specialized cell 
types for therapeutic applications.  
EBs emulate aspects of morphogenesis observed during embryonic development 
rendering them an invaluable cell source for studying the molecular mechanisms of 
embryonic morphogenesis. [48] For instance, EBs cultured under angiogenic conditions 
exhibit formation of primitive vascular structures and expression of pro-angiogenic 
growth factors [11,49,50]. The appearance of early tissue structures such as neurite 
extensions, indicative of neuronal differentiation, and contractile activity, indicative of 
cardiomyocyte differentiation, have also been observed during EB differentiation [51]. 
Recent studies have demonstrated the formation of more complex structures, including 
tissues resembling the optic-cup [52], brain [53], and thyroid follicle from pluripotent stem 
cell aggregates [54]. The process of cell specification during EB differentiation is 
governed by the deposition of extracellular matrix (ECM) and subsequent cell integrin-
ECM interactions. Additionally, various morphogens present in the embryonic 
environment collaborate with the ECM to coordinate the spatial and temporal 




harnessed by understanding the complex system of signaling molecules that function to 
control cell fate decisions. As many of these signaling proteins are derived from the 
extracellular matrix (ECM), manipulation of the ESC extracellular environment provides a 
means to alter stem cell behavior in order to induce specific cell behavior for therapeutic 
applications. 
 
2.4 Extracellular matrix-cell interactions 
2.4.1  Extracellular matrix in embryonic development 
In addition to the intrinsic properties of ESCs that direct cell fate, embryonic 
development is also governed by ECM-growth factor interactions. At the earliest stages 
of embryogenesis, cellsbegin to produce endogenous ECM components such as 
collagen, laminin, fibronectin, and glycosaminoglycans (GAGs) that serve an important 
role in the regulation of cellular proliferation and differentiation during [55–58]. For 
instance, laminin appears as early as the 2-cell stage [59] and fibronectin and type IV 
collagen appear in the inner cell mass of day 3/4 blastocysts [60]. The ECM functions to 
control the spatiotemporal release of growth factors, facilitate growth factor-receptor 
interactions, and mediate morphogen gradients by providing a reservoir of proteins [61]. 
During cell specification, the ECM also serves to define boundaries between different 
cell types and provide scaffolding for developing organs. Furthermore, ECM facilitates 
cellular migration by providing an adhesive substrate for cell attachment during 
embryogenesis. 
GAGs function to form morphogen gradients during early embryonic 
development by sequestration of secreted growth factors, thus directing the pattern of 
tissue morphogenesis. GAGs are ubiquitous in the pericellular space and are found 




GAGs are composed of linear polysaccharide chains consisting of repeating 
disaccharide units of an amino sugar (N-acetylglucosamine or N-acetylgalactosamine) 
and an uronic sugar (glucuronic acid or iduronic acid) or galactose and are classified into 
four types known as heparin/heparin sulfate (HS), chondroitin sulfate (CS)/dermatan 
sulfate (DS), keratan sulfate (KS), and hyaluronic acid (HA). In particular, HS has been 
extensively studied for its role in embryonic development, specifically in the regulation of 
FGF signaling where HS facilitates the formation of the FGF-FGFR complex [62–64]. 
Heparan sulfate (HS) is a negatively charged GAG that binds via electrostatic 
interactions to growth factors including VEGF, FGF2, and PDGF [65,66]. The sugar 
structure of HS chains consist of repeating units of glucuronic acid (GlcUA) and N-
acetylglucosamine (GlcNAc), which are polymerized by the enzymatic complex 
Exostosin1/2 (EXT1/EXT2) during chain eleongation [67]. The backbone of HS is 
subjected to further modification such as de-N-acetylation, N-sulfation, 6-O-sulfation, 3-
O-sulfation of glucosamine residues by enzymes N-deacetylase and N-sulfotransferases 
(NDST) as well as epimerization of GlcUA residues to iduronic acid (IdoUA) and 2-O-
sulfation of IdoUA residues [68,69]. The resulting HS structure is characterized by 
regions of variably sulfated groups separated by nonsulfated regions along the 
backbone [70,71]. In contrast, heparin, a closed related GAG, is highly sulfated along the 
entire backbone length. Sulfation patterns are critical for the regulation recognition of 
soluble and matrix proteins such as members of the FGF family, ultimately governing 






2.4.2  HS/heparin in stem cell differentiation 
The presence of GAGs is not only critical for embryonic development, but crucial 
for differentiation of ESCs in culture.  Interestingly, approximately 80% of GAGs 
synthesized by ESCs are HS chains [72,73]. HS is known to bind to various signaling 
molecules, such as BMP, Wnt, and FGFs that regulate ESC self-renewal and 
differentiation. For example, HS acts as a co-receptor in the formation of the FGF-FGFR 
complex to initiate intracellular FGF signaling and ultimately drive ESC differentiation 
toward other cell lineages. Undifferentiated ESCs express a low sulfated form of 
heparan sulfate (HS), but begin synthesis of more complex and sulfated variants of HS 
in a spatiotemporal manner as stem cells differentiate toward specific lineages [70–
72,74–76].  Furthermore, increases in overall sulfation are observed in ESCs undergoing 
differentiation [70,72,77]. It is hypothesized that remodeling of HS structure alters the 
affinity in of HS for specific biomolecules, ultimately affecting downstream signaling and 
cell fate decisions. For instance, neural differentiation is characterized by increased N- 
and 6-O- sulfation of HS chains, resulting in decreased binding of FGF2 as compared to 
HS of undifferentiated ESCs [70]. Microarray technology has also been utilized to probe 
GAG-protein interactions to demonstrate that HS binding with proteins is dependent on 
specific sulfation patterns [78].  
Targeted deletion of chain elongation enzymes EXT1 or EXT1 prevents 
successful gastrulation in mice embryos and results in failure to form mesoderm and 
extrembryonic tissues [67][79].  In parallel, EXT1/EXT2-/- stem cells retain their 
pluripotency in vitro  and fail to undergo yield successful ectodermal or mesodermal 
differentiation, [70,73,80,81]. Genetic removal of NDST1 reduces the sulfation of heparin 
resulting in death of mice shortly after birth due to respiratory difficulties [82,83], while 
NDST2-deficient mice remain viable but are unable to produce sulfated heparin [84]. 




and ultimately remain in a pluripotent state even under  differentiation conditions in vitro 
[81,85].  EXT1-/- mouse ESCs (mESCs) fail to differentiate into Pax6+ neural precursor 
cells and BrachyuryT+ mesoderm due to limited FGF and BMP signaling [86]. 
Furthermore, NDST1/2-/- ESCs demonstrated reduced ERK1/2 phosphorylation, due to 
diminished FGF signaling even in the presence of exogenous FGF4 addition [81]. 
However, differentiation of heparin deficient ESCs can be recovered by the addition of 
soluble heparin to the culture medium [70,80,86].  Interestingly, the addition of soluble 
heparin to HS-competent ESCs has also been show to modulate differentiation.  
Supplementation of heparin to wild-type cells supported hematopoiesis at low 
concentrations, yet inhibited differentiation at high concentrations, demonstrating that 
GAGs can act as both positive and negative regulators of differentiation [80]. 
Furthermore, HS/heparin of specific concentrations, saccharide length, and sulfation 
pattern were observed to support the formation of Sox1+ neural progenitor cells from 






Figure 2.1. HS/heparin-based strategies for ESC differentiation. A) HS mediates 
intracellular signaling through the sequestration and binding of growth factors. For 
example, heparin facilitates the formation of the ternary HS-FGF-FGF complex to induce 
Erk1/2 phosphorylation and subsequent gene transcription. B) Heparin-dependent 
signaling pathways are reduced in heparin-deficient ESCs, but addition of exogenous 
heparin or heparin mimetic materials can be used to rescue or enhance ESC 





2.5  Biomaterial strategies for directed stem cell differentiation 
2.5.1  ECM-mimetic materials that regulate growth factor activity  
The niche encompasses the stem cell microenvironment, including growth 
factors, cell-cell interactions, and cell-matrix contacts that work together to regulate cell 
fate.  In embryonic development, growth factors are tightly regulated in a spatiotemporal 
manner to regulate cell fate.  For in vitro cell culture, growth factors can be 




impart control over niche interactions in vitro is use of synthetic or naturally derived ECM 
biomaterials. Fabrication of ECM materials that preserve the unique signaling 
capabilities of native ECM enhances the potential of biomaterials to be used for 
regenerative therapies. Fabrication of biomaterials that incorporate heparin, chondroitin, 
laminin, and other ECM components have been used to localize and concentrate growth 
factor activity [88,89]. Therefore, engineering materials that mimic the ECM in its ability 
to actively sequester proteins have gained significant interest to regulate stem cell 
behavior. Ultimately, manipulation of ECM-cell interactions can be used to regulate 
growth factor signaling and improve the generation of defined cell populations as well as 
enable advancement of stem cell-based therapies.  
 
2.5.1a Synthetic strategies to localize growth factor activity 
A number of synthetic biomaterial strategies have been employed to mimic the 
ability of the ECM in order to regulate growth factor activity through the binding and 
release of molecules present in the cellular microenvironment. Synthetic peptides that 
mimic native GAG growth factor binding abilities have been investigated. PEG hydrogel 
microspheres with incorporated synthetic VEGF binding peptides were synthesized to 
reversibly bind VEGF, enabling targeted control over upregulation or downregulation of 
signaling activity by either release or sequestration [90,91].  Hubbell et al. identified 
synthetic heparin mimetics by screening a library of peptides with specific sulfate groups 
that bound VEGF with high affinity [92]. Synthetic peptides with variable sulfation 
patterns were synthesized that bound with high affinity and specificity to multiple 
heparin-binding peptides, such as human platelet factor 4 and antithrombin III, and 




growth factor activity, but with improved levels of specificity for growth factors of interest 
as compared to native ECM which interacts with a multitude of biomolecules. 
Cell surface engineering strategies to mimic the function of native HS-mediated 
growth factor signaling have been investigated. Remodeling of the glycocalyx, a 
glycoprotein-polysaccharide complex surrounding the cell membrane, has emerged as a 
promising method to introduce specific glycan epitopes to the cell surface to influence 
various biological processes, such as GAG-growth factor interactions. Synthetic 
neoproteoglycans (neoPGs) with affinity for FGF2 were incorporated into plasma 
membranes of heparin deficient ESCs in order to rescue FGF-mediated kinase signaling 
and support neural differentiation [94]. Membranes of neurons were remodeled with CS 
functionalized-liposomes, inducing increased activation of key neurotrophin signaling 
pathways and enhanced axon outgrowth from cells [95]. Accelerated neural 
differentiation was observed in mESCs with membrane-bound HaloTag proteins (HTPs) 
functionalized with specific HS derivatives [96]. While remodeling of the glycocalyx 
presents a unique opportunity to regulate cell signaling, strategies to control presentation 
of specific glycan epitopes, such as manipulation of metabolic pathways for glycan 
biosynthesis [97,98], covalent grafting of glycans to surface proteins [99], or passive 
incorporation of synthetic glycans into the cell membrane [100,101], rely on altering the 
native cell structure. 
 
2.5.1b ECM-derived biomaterials for localized growth factor activity 
Cell-derived ECM has been previously used to in culture to support cell 
expansion and differentiation in vitro, in addition to in vivo tissue regeneration [102,103].  
Decellularization of ESC aggregates has been performed to isolate and characterize 




Decellularized ECM (dECM) obtained from undifferentiated ESC monolayers, 
undifferentiated aggregates, and differentiated EBs at various stages of lineage 
specifications influenced ESC proliferation and differentiation, suggesting that dECM 
maintains its signaling capability [79,107]. ECM derived from ESCs and fibroblasts were 
used to direct cell specification of naïve mESCs, where differentiation of cells toward 
definitive endoderm was enhanced with laminin addition [108]. Ultimately, bioactive ECM 
could potentially be utilized as a scaffold to regulate ESC differentiation; however, more 
thorough characterization, such as mass spectrometry analysis, of morphogenic factors 
retained by dECM is necessary to completely identify the complex milieu of factors that 
work together to govern cell fate. 
Due to their strong binding interactions with a variety of growth factors present in 
the ESC microenvironment, GAGs present an attractive source for the fabrication of 
biomaterial delivery vehicles. Past approaches to immobilize GAGs on biomaterials have 
focused on incorporation of sulfated GAGs within polymer gels or covalent attachment of 
GAGs onto synthetic scaffolds. In particular, heparin and HS have been covalently and 
non-covalently incorporated into biomaterials for the delivery of well-known heparin 
binding growth factors. Heparin has been conjugated to fibrin [109,110], PLGA [88] and 
polyethylene (PEG) [111] gels for sustained release of factors such as FGF2 and VEGF. 
Other studies have examined the effect of heparin and other GAGs, without addition of 
exogenous factors. Notably, stem cells cultured on heparin-PEG gels demonstrated 
decreased activation of mitogen-activated protein kinase (MAPK), a critical protein in the 
FGF signaling pathway [111]. These results suggest that heparin is capable of binding 
FGF2 and modulating downstream signaling. Encapsulation and coculture of MSCs with 
osteoblasts in heparin-functionalized PEG gels exhibited improved osteogenic 
differentiation, suggesting that heparin limited the diffusion of osteoblastic factors away 




polymerized alluylamine (ppAm) electropsun scaffolds to provide signaling cues to 
seeded ESCs during culture [113]. The fabrication of electrospun meshes with non-
covalent immobilization of heparin was used to mimic the fibrous architecture of the 
native ECM and ultimately support the expansion and neural differentiation of ESCs. 
Non-covalent interactions of heparin and biomaterials have also been explored. Self-
assembling monolayers (SAMs) fabricated with heparin-binding peptides were used to 
sequester heparin present in serum, resulting in enhanced MSC proliferation and 
osteogenic differentiation through local amplification of FGF and BMP signaling activity 
[114,115]. Improved signaling was achieved without supraphysiological doses of soluble 
growth factor supplementation, providing further evidence that GAG-based materials can 
be used to study the influence of endogenous factors on cell behavior.   
In contrast to previously described materials that incorporated ECM or GAG 
components within polymer networks, the fabrication of microparticles (MPs) composed 
solely of GAG or ECM has been established as a novel means to improve growth factor 
binding and retention as well as delivery to specific cell populations. MPs composed of 
heparin-methacrylamide (HMAm) demonstrated improved binding of several heparin-
binding proteins such as BMP2, VEGF, and bFGF over other growth factor delivery 
vehicles, as well as maintaining growth factor bioactivity when used to stimulate ALP 
activity in skeletal myoblasts [116]. Similarly, chondroitin sulfate methacrylamide (CSMA) 
micro- and nanoparticles were synthesized to characterize the electrostatic interaction 
and release between positively charged TGF-β1 and negatively charged TNF-α from 
CSMA particles [117]. Furthermore, fabrication of MPs from gelatin, obtained from 
denatured collagen, provides a biomaterial that not only binds and releases growth 
factors such as BMP4 and bFGF, but can be degraded by collagenase to modulate 





2.5.2  Microparticles for ESC differentiation 
Strategies to direct differentiation of embryonic stem cell EBs often employ an 
“outside-in” approach by addition of soluble factors to culture medium. For example, 
soluble BMP4 is often added to induce mesoderm differentiation in ESCs. However, 
diffusion into EBs is limited by the formation of a dense outer layer composed of ECM 
and cells [119]. One method to direct differentiation and potentially overcome diffusion 
limitations is incorporation of engineered MPs, which have been widely used to control 
delivery of entrapped molecules, within 3D aggregates. Multiple parameters such as MP 
size, material, and delivery of small molecules or growth factors have been examined to 
determine their influence on stem cell differentiation. For example, incorporation of 
poly(lactic-co-glycolic acid) (PLGA) MPs of varied diameters demonstrated that MP size 
can modulate stem cell differentiation [120].  
 Several studies have examined the delivery of growth factors or small molecules 
from MPs incorporated within EBs. Delivery of retinoic acid via PLGA MPs incorporated 
within aggregates induced formation of cysts, with an outer epiblast layer resembling the 
structure of an early stage mouse embryo [121]. Furthermore, delivery of PIGF, VEGF, 
and bFGF from PLGA MPs demonstrated enhanced differentiation of hESCs down the 
vascular lineage, and limited differentiation toward ectoderm and endoderm [122].  
PLGA MPs loaded with simvastatin or BMP2 were incorporated within EBs to promote 
osteogenic differentiation, while MPs loaded with VEGF demonstrated improved 
endothelial differentiation [123].  Local delivery of BMP4 and thrombopoietin by 
incorporated type A gelatin microparticles functionalized with heparin enhanced the 
generation of hematopoietic progenitors as compared to soluble bulk delivery [124]. Both 
gelatin and heparin-functionalized gelatin MPs have been utilized to deliver BMP4 to 
support mesoderm differentiation, requiring almost 12-fold less total protein as compared 




has also been used to direct differentiation of multipotent stem cells. Chondroitin sulfate 
fabricated microparticles were used to deliver TGFβ to examine chondrogenesis within 
mesencyhmal stem cell (MSC) aggregates [126].  These results demonstrate that 
localized release of drugs or morphogenic factors directly within stem cell aggregates 
can direct differentiation. While MP mediated delivery of growth factors to stem cell 
aggregates has been successfully used to direct differentiation, previous studies have 
also observed that different materials used to fabricate MPs can also be modulate cell 
fate. For instance, agarose, PLGA, and gelatin microparticles affected the emergence of 
specific ell phenotypes [127]. Ultimately, the development of a new class of biomaterials 
capable of capturing and modulating the activity of stem cell derived morphogens in a 






pNIPMAm MICROPARTICLES FOR DELIVERY OF BMP4 TO 
PLURIPOTENT STEM CELL AGGREGATES 
 
Introduction 
Embryonic stem cells (ESCs) were first derived from the inner cell mass of 
mouse blastocysts and represent a unique cell population that can differentiate into all 
three embryonic germ layers (endoderm, mesoderm, and ectoderm), rendering them an 
invaluable cell source for studying the molecular mechanisms of embryonic 
morphogenesis [17,18].  While previous studies have modeled differentiation of ESCs in 
monolayer, formation of ESC aggregates, known as embryoid bodies (EBs) can be used 
to model the organization, migration, and differentiation of cells during embryonic 
development [48,51,128,129]. The spatial and temporal differentiation of ESCs within 
EBs is regulated by numerous coordinated interactions between soluble factors, cell-cell 
interactions, and extracellular matrix, which help to define the biochemical and 
mechanical properties of the EB microenvironment to regulate cell fate [128,130].  
Strategies to direct differentiation of ESC aggregates often employ an “outside-in” 
approach by addition of soluble factors to culture medium. For example, soluble BMP4 is 
often supplemented to direct mesoderm differentiation by inducing expression of 
transcription factor BrachyuryT [28,131]. However, the formation of a dense outer layer 
composed of ECM and cells during EB differentiation limits the diffusion of exogenously 
added soluble factors, which may in part, be responsible for heterogenous cell 




potentially overcome diffusion limitations is incorporation of engineered microparticles 
(MPs), which have been widely used to control molecular delivery locally, within 3D 
multicellular aggregates [121,122,124,125]. Delivery of retinoic acid via PLGA MPs 
induced formation of cystic cavities within aggregates [121], whereas gelatin and 
heparin-functionalized MPs have been used to delivery BMP4 to support mesoderm 
differentiation, requiring almost 12-fold less total protein as compared to traditional bulk 
delivery methods [125].  However, MP synthesis is limited with respect to control over 
uniformity in MP size, growth factor payload, and release rates. 
The use of synthetic materials offers customized control over biomolecule 
release as the physical and chemical properties, such as degree of crosslinking, overall 
charge, and type of polymer,can be altered for specific stem cell differentiation strategies 
[128]. Commonly used in drug delivery and tissue engineering applications, hydrogels 
are three-dimensional networks of physically or chemically cross-linked, hydrophilic 
polymers that can be designed to mirror the flexibility of native tissuedue to their high 
water content (~90%) [134–137].  Hydrogel properties such as overall charge, which can 
enhance loading or retention of biomolecules, and network mesh size, which determines 
the mobility and diffusion rate of embedded biomolecules and is characterized by the 
cross-linking density and polymer-solvent interactions, can also be tailored for specific 
applications [138].  Furthermore, hydrogels maintain growth factor bioactivity for delivery.  
Biomolecule loading is performed by the “breathing in” method, in which a concentrated 
volume of protein is added to lyophilized hydrogels, where upon exposure to water, 
hydrogels swell and imbibe growth factors [139].  
Poly(N-isopropylacrylamide) (pNIPAM), a commonly used thermosensitive 
polymer can be chemically modified by the addition of a methyl group to form p(N-
isopropylmethacrylamide) (pNIPMAm). Increasing the transition temperature from  1 to 




temperatures and permit passive diffusion of entrapped soluble factors. Hydrogel MPs, 
termed microgels  ranging in size from 100 nm to 1μm, have been previously fabricated 
from pNIPMAm  for use in drug delivery studies [140–143]. “Raspberry-like” particles 
composed of core polystyrene MPS surrounded by a shell of microgels have been 
fabricated using colloidal-phase mediated heteroaggregation [144]. Ultimately, coupling 
of pNIPMAm microgels to core particles combines the hydrophilic and morphogen-
releasing properties of hydrogels with a dense material that enhances incorporation 
within EBs. The overall objective of this study was to characterize pNIPMAm MPs for 
controlled delivery of bioactive BMP4 and incorporation in ESC aggregates. 
 
Methods 
Synthesis and characterization of pNIPMAm MPs 
The MP construct is a core-shell structure. The shell consists of microgels 
composed of 68% N-isopropylmethacrylamide (NIPMAm), 2% N,N’-
methylenebis(acrylamide) (BIS), 30% acrylic acid (AAc) and was synthesized by 
precipitation polymerization[1].  Microgels were synthesized by dissolving 140 mM of 
NIPMAm and BIS in dI H2O to a final total monomer concentration of 140 mM and 
purged with nitrogen for 1 hour. AAc and ammonium persulfate (APS) were added and 
the solution was held at ~70 °C overnight. The microgel solution was filtered through 
glass wool, purified via centrifugation, and lyophilized for storage. Microgel 
hydrodynamic radius (RH) values were determined using a DynaPro Dynamic Light 
Scattering (DLS) system (Wyatt, Technology, Santa Barbara, CA). Carboxylated-PS 
core particles (Spherotech, Inc, Lake Forest, IL) were functionalized with 4-




Microgel heteroaggregates were prepared by solvating microgels in dI H2O and mixing 
with AB-functionalized core particles resuspended in 0.75% w/w ethanol. The samples 
were exposed to UV for 30 minutes and purified via sequential centrifugation. 
Microparticles were imaged using a NOVA FIB FEI Scanning Electron Microscope (FEI, 
Hillsboro, OR) and a Zeiss confocal microscope.  All reagents were purchased from 
Sigma-Aldrich (St. Louis, MO). 
BMP4 loading and release from MPs 
MP concentration in PBS was counted using a hemacytometer. MPs were 
dehydrated prior to growth factor loading by resuspending MPs in 70% ethanol in 
microcentrifuge tubes and allowing for evaporation of ethanol overnight at room 
temperature. Lyophilized BMP4 (R&D) was resuspended in 0.1% BSA in PBS prior to 
addition to dehydrated MPs. The BMP4 binding capacity of MPs was examined by 
addition of 1 ml of a low (10ng/mg MP) and high (100 ng/mg MP) dose of  BMP4 in 
0.1%BSA over 18 hours at either 4 °-C  to promote rehydration of  MPs and subsequent 
uptake of BMP4. Depletion of BMP4 from solution by MPs from the growth factor 
solution was quantified by analyzing the supernatant BMP4 concentration via an 
enzyme-linked immunosorbent assay (ELISA). After addition of BMP4 solution, MPs 
were centrifuged at 5,000 RPM for 5 minutes for removal of supernatant (or unbound 
BMP4). One ml of 0.1% BSA in PBS solution was added to pelleted MPs. Passive 
release of BMP4 at 37 ° C was determined by removal of 300 µl of supernatant after 
centrifugation of BMP4-loaded MPs every day for the first week of release and at two 
weeks. 
Alkaline phosphatase (ALP) activity assay 
Skeletal myoblasts (C2C12) were seeded at 20,000 cells per well in a 96-well 




Cells were then switched to low serum media (DMEM with 1% FBS) immediately prior to 
treatment with soluble BMP4, unloaded MPs, unloaded MPs and soluble BMP4, or 
BMP4 loaded MPs. ALP activity of C2C12 cells was quantified by addition of 50 μL of 
cell lysate with 50 μL of CellLytic M and 100 μL of substrate solution consisting of 3.33 
mM MgCl2 (VWR, West Chester, PA), 400 mM 2-amino-2-methyl-1-propanol (Sigma 
Aldrich), and 6.67 mM p-nitrophenyl phosphate (pNPP, Sigma Aldrich). After termination 
of the reaction with 0.2 M NaOH, the absorbance was measured at 405 nm on a 
microplate reader (Biotek, Winooski, VT) and total ALP activity was determined using a 
standard curve generated from 4-nitrophenol.  
Cell culture 
Undifferentiated D3 ESCs were maintained in monolayer culture on 0.1% gelatin 
coated tissue culture dishes in Dulbecco’s modified Eagle’s medium (DMEM) media with 
high glucose supplemented with 15% fetal bovine serum (FBS) (Hyclone), 2 mM L-
glutamine (Gibco), non-essential amino acids (NEAA) (Gibco), penicillin and 
streptomycin (Gibco), 0.1mM β-mercaptoethanol (Gibco), and 103 U/ml leukemia 
inhibitory factor (LIF). D3 ESCs were cultured at 37 °C in a humidified 5% CO2 
atmosphere.  Approximately 10 mL of media was exchanged  during ESC culture 
occurred every 2 days and cells were passaged every 3 days before reaching 
approximately 75% confluency. Monolayer cultures of undifferentiated BMP sentinel 
cells were maintained in the KO-N2B27 media composed of Knock-out DMEM (Gibco) 
supplemented with N2 (Gibco) , B27 (Gibco), 100 U/ml penicillin, 100 U/ml 
streptomyocin, 0.25 mg/ml amphotericin, 2 mM L-glutamine, 10 ng/ml bone 
morphogenetic protein 4 (BMP4) and 103 U/ml LIF. Serum-free KO-N2B27 media without 




Embryoid body formation and culture 
Prior to EB formation, ESCs were trypsinized into single-cell suspension culture. 
EBs were formed by forced aggregation of single cell ESCs in micro-well inserts 
composed of 3% agarose. Briefly, 1000-cell EBs were formed by addition of 1.2 million 
cells resuspended in 0.5 ml of media and added to each insert, containing approximately 
1200 wells. Inserts containing cells were centrifuged at 200 x g for 5 minutes to 
aggregate cells within individual wells. After 18 hours of culture, aggregated cells were 
removed from wells by gently pipetting with a wide bore pipette tip. Next, EBs were 
transferred in petri dishes at a concentration of 1200 EBs/ml and maintained in KO 
N2B27 media. EBs were maintained in suspension culture on rotary orbital shaker at 45 
RPM to prevent agglomeration. EBs were re-fed every 3 days and 90% of spent media 
was exchanged with fresh media. In studies using BMP4 supplementation, 10 ng/ml of 
soluble BMP4 was added to culture media during initial centrifugation of ESCs in inserts, 
after transfer of EBs to suspension culture, and at all subsequent media exchanges. 
Prior to centrifugation, MPs were resuspended with ESCs in media and added to inserts. 
After 24 hours of formation, aggregates were collected and volumes chose to contain 
approximately 40-50 aggregates from each MP to cell incorporation ratio was chosen to 
count the precise number of aggregates per volume. After enzymatic dissociation of 
aggregates, the number of MPs was counted using a hemacytometer and normalized to 
the number of lysed aggregates to determine the number of MPs incorporated per EB. 
Gene expression analysis 
Differentiation of EBs treated with BMP4-loaded MPs was assessed via 
quantitative PCR.  RNA was extracted from undifferentiated ESCs and EBs at Day 2, 4, 
and 6 of differentiation using the RNeasy Mini Kit (Qiagen). Reverse transcription of 




(BioRad) and was analyzed using SyberGreen technology on the MyIQ cycler (BioRad). 
Forward and reverse primer sequences for Oct4, Nanog, BrachyuryT, Flk1, Pax6, AFP, 
and 18S were designed with Beacon Design software and are described in Table 1. 
Gene expression was quantified with respect to levels of gene expression of 
undifferentiated ESCs and EBs without MPs or BMP4 supplementation. 
 
Table 3.1. PCR sequence and conditions for qPCR 
Gene Forward Sequence Reverse Sequence Melt Temp 
18S CTCTAGTGATCCCTGAGAAGTTCC ACTCGCTCCACCTCATCCTC 58.0 
Oct-4 CCG GTGAGGTGGAGTCTGGAG GCGATGTGAGTGATCTGCTGTAGG 58.0 
Nanog GAA ATCCCTTCCCTCGCCATC CTCAGTAGCAGACCCTTGTAAGC 58.0 
Brachyury-T CACACCACTGACGCACAC GAGGCTATGAGGAGGCTT TG 58.0 
Flk-1 GGCGGTGGTGACAGTATC TGACAGAGGCGATGAATGG 64.3 
Pax-6 ACGGCATGTATGATAAACTAAG GCTGAAGTCGCATCTGAG 58.0 
AFP CACACCCGCTTCCCTCATCC TTCTTCTCCGTCACGCACTGG 58.0 
 
Histology 
EBs were collected, fixed in 10% formalin, and embedded in Histogel (Thermo 
Scientific), processed and paraffin embedded. Paraffin embedded samples were cut into 
5 μm thick sections (Microm HM  55S). Deparaffinized sections were stained with 
hematoxylin and eosin (H&E) and imaged with a Nikon 80i upright microscope using the 






EBs were washed with PBS and dissociated to single cell suspension with 0.25% 
trypsin-EDTA and trituration for 10 minutes. The single cell suspension was washed 3 
times in PBS and fixed in 10% formalin with centrifugation at 200 x g for 5 minutes 
between each wash. Flow cytometry was performed with a BD LSRII flow cytometer 
(Becton Dickinson, East Rutherford, NJ) with a minimum of 10,000 events per sample 
collected within the FSC/SSC gate for cell populations. Microparticles and 
undifferentiated BMP sentinel cells were used to establish appropriate gates and 
controls. Polygonal gating was used on the FSC/AmCyan (405 nm excitation; 491± 
emission) plots to limit 1% of untreated embryoid body population (“No MP” group) via 
FlowJo software (Tree Star, Inc., Ashland, OR). 
Confocal microscopy 
The presence of rhodamine-labeled microgels and CFP expressing sentinel cells 
within EBs was analyzed using a LSM 700-405 confocal microscope (Zeiss, Thornwwod, 
NY). EBs were washed in PBS 3 times, fixed in 10% formalin for 30 minutes, and 
stained with either Hoescht (1:100) or ethidium homodimer (1:500) before imaging. 
Statistical Analysis 
ll data are reported as mean ± standard error for a minimum of triplicate 
experimental samples.  A Box-Cox power transformation was used to normalize data to 
a Gaussian distribution before statistical analysis. Statistical significance was assessed 
using a one-way ANOVA with Tukey’s post hoc analysis. A p-value of less than 0.05 was 







pNIPMAm MP characterization 
pNIPMAm MPs were fabricated using a modified version of colloidal-phase 
mediated heteroaggregation in order to produce large batches of microparticles to 
enable investigation of in vitro applications (Figure 3.1). Phase images of pNIPMAm 
MPs indicated that MPs exhibit round shapes and a low polydisperse population (Figure 
3.2A). SEM imaging revealed that polystyrene core particle are fully covered by a shell 
of microgels, presenting a soft, biocompatible surface to surrounding cells (Figure 3.2B). 
Confocal imaging of rhodmaine functionalized microgels indicated that microgels were 
fully swollen and cover the majority of the core particle in solution (Figure 3.2C).  
Fabrication of MPs produced approximately 18 million MPs per mg of polymer with an 









Figure 3.1. Schematic of pNIPMAm MP synthesis. The MP construct is a core-shell 
structure synthesized by preciptitation polymerization. The the shell consists of 
microgels composed of 68% NIPMAm, 2% BIS, 30% AAc Carboxylated-PS core 
particles were functionalized with 4-aminobenzophenone using EDC/NHS chemistry 
Microgel hetteroaggregates were prepared by mixing microgels functionalized core 
particles and exposing samples to UV. 
 
 
BMP4 loading and release from pNIPMAm MPs 
The hydrophilic nature of the microgels promotes immediate swelling upon 
exposure to water, subsequently imbibing growth factors present in the surrounding 
solution. Additionally, microgels are negatively charged due to their acrylic acid content, 
allowing for electrostatic interactions with positively charged BMP4 (pI = 8.97). The 
binding capacity of MPs for BMP4 was examined by measuring the depletion of BMP4 
from solution, ranging in concentration from 2-2,000 ng protein per milligram of MP 
(Figure 3.2E). MP binding capacity of BMP4 increased with increasing concentrations of 
BMP4. Below 100 ng per mg of MP, the relationship between MP bound BMP4 and 
loading concentration of BMP4 was relatively linear (R2 = 0.998) with approximately 




ng per mg MP, the efficiency of BMP4 binding decreased to approximately 45.0% ± 
14.9%.  
Release of BMP4 from MPs was assessed at low (10 ng per mg of 
microparticles) and high (100 ng per mg of microparticles) concentrations of BMP4 at 37 
°C. MPs loaded with the high concentration of BMP4 demonstrated a greater initial burst 
release within the first 3 hours (< 40%) and released a larger amount of BMP4 over 14 
days than MPs loaded with a low concentration of BMP4 (Figure 3.2F). Independent of 
initial loading mass, MPs loaded with both low and high concentrations of BMP4 
exhibited sustained release over the first 7 days. Overall, total release of BMP4 after 14 
days was approximately 60% of loaded protein, indicating that the majority of the protein 





Figure 3.2. pNIPMAm MP characterization. (A) Phase image of MPs demonstrates the 
even polydispersity and spherical shape of particles. (B,C) Colloidal-phase mediated 
heteroaggregation was scaled up to produce uniformly coated MPs as indicated by SEM 
and confocal imaging (D) Coulter counter size analysis of MPs demonstrates a narrow 
size distribution with an average diameter of  .6 ± 1.0 μm. (E) MPs demonstrated 
increased growth factor binding capacity with increasing initial growth factor loading 
concentrations. Average loading efficiency for BMP4 was 55.5 ± 6.2%. (F, G) Release of 
BMP4 from MPs was directly dependent on the initial loading amount of BMP4 and 
demonstrated increased release for 7 days with less than 60% of BMP4 was released at 





Delivery of BMP4 via pNIPMAm MPs to skeletal myoblasts 
Bioactivity of BMP-4 loaded MPs was evaluated using an in vitro alkaline phosphatase 
(ALP) assay to quantify ALP activity of skeletal myoblasts (C2C12s), following treatment with 
soluble BMP4, unloaded MPs, unloaded MPs and soluble BMP4, or BMP4 loaded MPs. 
Treatment with BMP4 loaded MPs induced ALP activity similar to delivery of soluble BMP-4, 
suggesting that loaded MPs maintain BMP-4 bioactivity and ability to initiate a functional 
response, even with less than 25% release of BMP4 (Figure 3.3A). Overall, treatment of cells with 
BMP-4 (soluble or loaded) demonstrated increased ALP activity as compared to unloaded MP 
and untreated groups. Interestingly, simultaneous treatment of unloaded MPs and soluble BMP4 
induced significantly less ALP activity in comparison to soluble BMP4 treatment, suggesting that 
MPs may sequester free BMP-4 and prevent subsequent interactions with cells. No differences in 





Figure 3.3. BMP4 bioactivity was evaluated by quantifying ALP activity of C2C12 
cells after 3 days of treatment. BMP4 (soluble or loaded) increased ALP activity 
compared to unloaded MP and No MP. BMP4 MPs induced similar ALP activity to 
soluble BMP4, indicating comparable bioactivity. Unloaded MPs with soluble BMP4 
induced less ALP activity compared to soluble BMP4 alone, suggesting that MPs 
actively sequester free BMP4 and prevent interactions with cells.  ( n =3; p<0.05 











Incorporation of pNIPMAm MPs in EBs  
MPs were incorporated within ESC aggregates using forced aggregation via 
centrifugation within agarose microwells at 1:10, 1:3, 1:1, and 3:1 (MP:cell) seeding 
ratios. Rhodamine B-labeled MPs incorporated within aggregates were identified by 
fluorescent and confocal microscopy (Figure 3.4A). Maximum  MP incorporation within 
aggregates was achieved with approximately 80 MPs per ESC aggregate at a MP to cell 
seeding ratio of 1:1 (Figure 3.4B), which was used for all subsequent studies. 
Incorporation efficiency of microparticles within aggregates decreased as the number of 
MPs to cell ratio increased (Figure 3.4C). Additionally, formation of uniform ESC 
aggregates in the presence of 3:1 seeding ratio was hindered, which may, in part, be 
due to  lack of cell-adhesive sites on MP constructs that prevented formation of  cell-cell 





Figure 3.4.  MPs are incorporated within pluripotent stem cell aggregates.(A) ESCs 
were centrifuged alone or with rhomadine –labeled  MPs to form aggregates in μ-wells 
before transfer to rotary orbital suspension culture. MPs were incorporated in EBs at 
MP:cell seeding ratios of 1:10, 1:3, 1:1 and 3:1. (B) Maximum MP incorporation was 
approximately 80 MPs per EB at a 1:1 ratio. MP incorporation efficiency was < 20% for 




Delivery of BMP4 via pNIPMAm MPs to EBs  
MPs were used to deliver BMP4 within ESC aggregates to promote mesoderm 
differentiation under serum-free conditions. BMP4 delivery by pNIPMAm MPs to ESC 
aggregates was compared to unloaded MPs and treatment with soluble BMP4 
(10ng/mL) with or without incorporation of unloaded MPs (Figure 3.5). BMP4 was 




The total corresponding amount of growth factor delivered via MPs to 1200 EBs per 
culture plate was 10 ng of BMP4. Subsequently, growth factor delivery via MPs was 10-
fold less than the total amount of soluble BMP4 supplemented at the beginning of EB 
culture (Day 0). Incorporation of pNIPMAm MPs within EBs did not appear to have any 
gross effect on cell morphology through 6 days of culture (Figure 3.5).   
Gene expression of pluripotency markers, Oct4 and Nanog, early lineage 
commitment markers, BrachyuryT, Flk1, Pax6, and AFP, were analyzed at day 6 of 
differentiation (Figure 3.6) As expected, all experimental groups demonstrated 
decreased expression of pluripotent transcription factors Oct4 and Nanog over the 
course of differentiation. No significant differences in BrachyuryT expression were 
observed between treatment groups. However, delivery of soluble BMP4 loaded MPs 
resulted in increased expression of the mesoderm marker, Flk-1, and decreased 
expression of ectoderm marker, Pax6. BMP4 loaded MPs demonstrated similar 
expression of Flk1, Pax6, and AFPcompared to soluble delivery. Interestingly, only ESC 
aggregates treated with BMP4 loaded MPs demonstrated significant differences in Pax6 













Figure 3.5. BMP4 loaded pNIPMAm MPs were incorporated in EBs via forced 
aggregation. BMP4 loaded MPs were incorporated in EBs via forced aggregation in 
agarose μ-wells and maintained in rotary suspension culture at 40 RPM for 6 days.  
Hematoxylin & eosin staining of Day 7 aggregates with or without treatment of soluble or 





Figure 3.6. BMP4 loaded MPs incorporated within pluripotent stem cell aggregates 
induces mesoderm differentiation. Directed differentiation of ESCs via soluble or  MP 
delivery of BMP4 induced comparable levels of early lineage commitment markers, 
despite delivery of 10 fold less BMP4 by  MPs. Expression of pluripotency markers, Oct4 
and Nanog, decreased over the course of culture and demonstrated no changes 
between any of the treatment groups. Soluble or  MP delivery of BMP4 induced 
comparable expression of Flk1 (mesoderm) and AFP (endoderm) in day 6 ESC 
aggregates, however no differences in expression of mesoderm marker, BrachyuryT, 
was observed. Interestingly, only ESC aggregates treated with BMP4 delivered via  MPs 
demonstrated significant decreased expression of Pax6 (ectoderm). (*= significantly from 
no MP;$=significant from unloaded MP;%=significantly from unloaded MP +  soluble 
BMP4, n = 5; p<0.05) 
 




BMP Signaling in ESCs 
BMP sentinels allow for monitoring of the spatial and temporal presentation of 
BMP signaling in differentiating ESC aggregates in response to MP delivery of BMP4. 
ESC signaling sentinels were created with response elements for BMP (IBRE-4-CFP) 
inserted at the -228 site of the endogenous Rosa26 locus [145]. CFP expression peaked 
at day 2 of differentiation for all groups, with maximum CFP expression observed in 
samples treated with BMP4 loaded MPs. At day 2, EBs were fixed and counterstained 
with a nuclear dye (Hoescht) and imaged using a confocal microscope (Figure 3.7A). 
Little CFP expression was observed in untreated ESC aggregates or ESC aggregates 
with unloaded MPs. In contrast, CFP expression was observed throughout ESC 
aggregates treated with soluble BMP4 or BMP4 loaded MPs.  
CFP expression was quantified by flow cytometry of positive ESCs after 
dissociation of day 2 aggregates (Figure 3.7B,C). At day 2 of differentiation, CFP 
expression was limited in the untreated (1.2 ± 0.1%) and unloaded MP (1.1 ± 0.1%) 
groups. BMP4 delivered by MPs exhibited significantly greater expression of CFP 
positive cells (21.0 ± 1.8%) at 2 days of culture as compared to all other groups. Soluble 
addition of BMP4 demonstrated significantly higher CFP expression (6.0 ± 0.6%) as 
compared to untreated and unloaded MP groups. Interestingly, ESC aggregates treated 
with unloaded  MPs and soluble BMP4 showed significantly more CFP expression (21.3 
± 0.2%) than ESC aggregates treated only with soluble BMP4, suggesting MPs may 
bind exogenous BMP4 via electrostatic interactions and attain a higher local 
concentration of BMP4. Positive CFP expression decreased to less than 5% for days 4 





Figure 3.7. BMP signaling in ESC aggregates. (A) BMP4 loaded MPs were 
incorporated in aggregates of BMP signal responsive sentinel ESCs with CFP 
fluorescence reporter.  Positive CFP expression was observed by confocal microscopy 
in groups with BMP4 (soluble or loaded) at day 2, while all other treatment groups 
exhibited little CFP expression. (B,C) Flow cytometry of CFP+ cells from dissociated 
ESC aggregates was performed at day 2. ESC aggregates treated with BMP4 loaded  
MPs expressed significantly more CFP (21.0 ± 1.8%) as compared to soluble delivery 
(6.0 ± 0.6%) of BMP4.(n=4; * = significantly from No MP; $ = significantly from Unloaded 






In this study, we demonstrated that pNIPMAm MP mediated delivery of BMP4 
within ESC aggregates can be used as a biomaterial based strategy to enhance ESC 
differentiation. MP characterization indicates that colloidal-phase mediated 
heteroaggregation produces a well-coated population of MPs with low heterogeneity in 
terms of microgel coverage. Consistent microgel coverage is critical for uniform 
presentation of material and growth factors to surrounding cells. Furthermore, microgel 
characterization indicated low polydispersity (~1 μm) as compared to previously 
explored delivery vehicles such as PLGA, heparin, or gelatin based MPs [116,120,127]. 
Low polydispersity of both microgels and MPs minimizes variations in loading and 
release rates of BMP4. MPs also exhibited minimal aggregation during lyophilization, 
which is ideal for delivery vehicles loaded with morphogens while in a dehyrated” state, 
and after incorporation within EBs, resulting in even distribution of MPs and uniform 
delivery of BMP4 throughout aggregates.  
The total amount of BMP4 released from MPs was dependent on initial growth 
factor loading concentration; however, more than 50% of BMP4 was released over a 
period of 14 days regardless of the initial amount of bound growth factor. Initial studies 
demonstrated that BMP4 released from pNIPMAm MPs was able to induce similar ALP 
activity in skeletal myoblasts as compared to soluble BMP4 treatment after 72 hours of 
culture, suggesting that BMP4 released from MPs remains bioactive. As previous 
studies have demonstrated that incorporation efficiency of MPs is directly related to 
material adhesivity, the low incorporation efficiency (< 10%) of pNIPMAm MPs was most 
likely due to lack of cell adhesive sites [127]. While no significant differences were 
observed in the formation of ESC aggregates at MP to cell seeding ratios of 1:10, 1:3, 




and less spherical shaped aggregates, suggesting MPs may interrupt the formation of 
necessary E-cadherin mediated cell-to-cell contacts for aggregation at seeding ratios 
higher than 1:1. For future studies, increased MP incorporation could be achieved by 
incorporation of Arg-Gly-Asp (RGD) or other cell adhesion sequences to microgels [146].   
 MP delivery of BMP4 within ESC aggregates resulted in similar expression of 
mesoderm and ectoderm markers as compared to soluble delivery. While no significant 
differences were observed in the expression of the transient mesoderm marker 
BrachyuryT, expression of Flk1 was significantly increased in groups treated with either 
soluble BMP4 or BMP4 loaded MPs. Under basal conditions, ESCs typically differentiate 
toward neuorectoderm, known as the default pathway [18]. However, expression of 
Pax6, an early marker of ectoderm, was significantly decreased in ESCs treated with 
BMP4 loaded MPs as compared to all other treatment groups, suggesting BMP4 loaded 
MPs may limit ESC differentiation toward ectoderm. Previous studies have 
demonstrated that BMP signaling is required during mesoderm specification to induce 
expression of Flk1+ hematopoietic mesoderm from cell populations expressing 
BrachyuryT [24,26]. BMP signaling is initiated by the interaction of BMPs with cell 
surface receptors that ultimately activate intracellular SMAD 1/5/8 signaling and 
subsequent gene transcription [21]. BMP signaling sentinels provide a unique tool to 
monitor the spatial and temporal activation of BMP signaling in ESC aggregates [145]. In 
accordance with the release profile of BMP4 from MPs, the highest CFP expression was 
observed at day 2 of culture, coinciding with the majority of BMP4 release from MPs, 
indicating that BMP4 loaded MPs can influence early ESC differentiation events. 
Maximum CFP expression was observed in ESC aggregates treated with BMP4 loaded 
MPs, indicating that MPs can present bioactive BMP4 to cells to induce BMP signaling. 
Interestingly, ESC aggregates treated with unloaded MPs and soluble BMP4 




suggesting that unloaded MPs may sequester soluble BMP4 and enhance the local 
concentration of BMP4 in direct contact with cells. The microgels of pNIPMAm MPs are 
composed of 30% acrylic acid and most likely attract native cationic morphogens, 
including BMP4, resulting in increased concentration of morphogens within ESC 
aggregates. Overall, these results demonstrate that the amount of BMP4 delivered by 
MP required 10-fold less total growth factor as compared to soluble delivery to modulate 
ESC differentiation, suggesting that growth factors presented from MPs can induce more 




Herein, we have demonstrated that synthetic pNIPMAm MP constructs can be 
used as an “inside-out” tool to control the release of morphogens within ESC 
aggregates. Synthesis of pNIPMAm constructs demonstrates low polydispersity and 
uniform distribution of microgels on polysystrene particles. MPs can load and release 
morphogens in a controlled manner within EBs, thus improving the efficiency of ESC 
differentiation by requiring 10-fold less BMP4 as compared to soluble delivery. By 
utilizing a synthetic approach to mediate morphogen delivery, the development of 
customized delivery vehicles for delivery of pre-loaded MPs or capture of endogenously 







HEPARIN-METHACRYLAMIDE (HMAM) MICROPARTICLES 
ENHANCE NEUROECTODERMAL DIFFERENTIATION OF 




Extracellular matrix (ECM) components, such as glycosaminoglycans (GAGs), 
play crucial roles in cell signaling and regulation of morphogen gradients during early 
embryonic development via binding and concentration of secreted growth factors 
[55,147].  GAGs are of specific interest as they regulate morphogen gradient formation 
during early embryogenesis by sequestering secreted biomolecules, thus directing 
patterns of tissue morphogenesis [148].  ESC aggregates, otherwise known as embryoid 
bodies (EBs), emulate aspects of morphogenesis observed during embryonic 
development by producing signaling molecules that direct tissue patterning during 
embryonic development [48].  As our understanding of the role of ECM in ESC biology 
increases, use of ECM analogues to alter GAG-mediated signaling pathways has 
emerged as a potent means to manipulate ESC differentiation more effectively. 
Differention of EBs can be directed by addition of soluble factors to the culture 
medium; however “outside-in” approaches  are limited by non-homogenous 
differentiation of EBs, as diffusion of soluble factors is limited by the formation of a dense 
outer layer composed of ECM and cells [119]. An alternative approach for directed 




[121,127,149]. In particular, MPs have been used previously as delivery vehicles for 
sustained release of morphogens and small molecules within 3D stem cell 
microenvironments [124–126]. Given that native GAGs modulate important ESC 
signaling pathways, supplementation of heparin via material incorporation may enable 
novel strategies to manipulate endogenous cell signaling. Heparin, similar in structure to 
heparan sulfate (HS), binds numerous ESC secreted growth factors in a reversible 
manner with high affinity (i.e. VEGF, FGFs, and BMPs) [68,150,151]. Thus, engineered 
biomaterials amenable to conjugation with highly sulfated GAGs, such as heparin, 
provide ideal matrices for manipulation and efficient capture of ESC morphogens via 
reversible electrostatic and affinity interactions.  
A number of material approaches have been employed to mimic the ability of the 
ECM to buffer growth factor activity through the binding and release of molecules 
present in the extracellular environment [90,113,152]. Previous work has demonstrated 
that the material of MPs can influence ESC differentiation within EBs [127]. As described 
in Chapter 1, unloaded pNIPMAm MPs demonstrated the ability to modulate cell 
behavior, providing further evidence that incorporation of MPs within EBs can modulate 
patterns of differentiation by material-growth factor or material-cell interactions. 
Promising results have demonstrated that addition of heparin to ESCs can enhance 
hemangioblast specification of cells and thus may play a key role in processes involved 
in vasculogenesis and angiogenesis [80,110,150]. Previously, heparin-derived MPs have 
been fabricated that are capable of sequestering large amounts of bioactive growth 
factors, such as BMP2, VEGF, and FGF2, and serve as a biomimetic material that 
dynamically regulates growth factor presentation [116]. Thus, biomaterials designed to 
efficiently capture and retain bioactive ESC-derived morphogens offer an attractive 







Undifferentiated D3 ESCs were maintained in monolayer culture on 0.1% gelatin 
coated tissue culture dishes in Dulbecco’s modified Eagle’s medium (DMEM) media with 
high glucose supplemented with 15% fetal bovine serum (FBS) (Hyclone), 2 mM L-
glutamine (Gibco), non-essential amino acids (NEAA) (Gibco), penicillin and 
streptomycin (Gibco), 0.1mM β-mercaptoethanol (Gibco), and 103 U/ml leukemia 
inhibitory factor (LIF). D3 ESCs were cultured at 37 °C in a humidified 5% CO2 
atmosphere.  Media was completely exchanged every 2 days and cells were passaged 
every 3 days before reaching approximately 75% confluency.  
Embryoid body formation and culture 
Prior to EB formation, cells were trypsinized into single-cell suspension culture. 
EBs were formed by forced aggregation of single cell ESCs in  00 μm micro-well inserts 
composed of 3% agarose. Briefly, 1000-cell EBs were formed by addition of 1.2 million 
cells resuspended in 0.5 ml of media and added to each insert, containing approximately 
1200 wells, in a 24-well plate. Inserts containing cells were centrifuged at 200 x g for 5 
minutes to aggregate cells within individual wells. After 18 hours of culture, aggregated 
cells were removed from microwells by gently pipetting with a wide bore pipette tip. Next, 
EBs were transferred to 100 mm petri dishes at a concentration of 1200 EBs/ml and 
maintained in either Knock-out DMEM (Gibco) supplemented with N2 (Gibco) , B27 
(Gibco), 100 U/ml penicillin, 100 U/ml streptomyocin, 0.25 mg/ml amphotericin, and 2 
mM L-glutamine or ESC culture media without LIF on a rotary orbital shaker at 45 RPM. 
EBs were re-fed every 3 days and 90% of spent media was exchanged with fresh media.  
Incorporation of HMAm MPs within ESC aggregates was performed by resuspending 




Collection and analysis of spent media 
At days 4, 7, 10 and 14 of suspension culture, EBs were collected in 15 mL 
conical tubes and allowed to sediment to the bottom of the tube. Media was removed 
and centrifuged at 10,000 RPM for 10 minutes to pellet cell debris. Supernatant media 
was collected and stored at -20˚C. Spent media was analyzed for FGF2, VEGF, BMP , 
and IGF2 concentrations via an ELISA assay (R&D Systems, Minneapolis, MN). 
HMAm MP incorporation analysis 
Heparin methacrylamide (HMAm) was synthesized as previously described [116]. 
Fluorescently labeled HMAm was fabricated by dissolving 300 mg HMAm in 30 ml of 0.1 
M Na2HPO4, 0.1 M EDC, and 10 mM Alexa Fluor 633 hydrazide (Life Technologes). The 
solution was allowed to react for 2 hours under stirring conditions at room temperature 
and then the total volume of reaction was dialyzed using 2000 kDA tubing (Spectrum 
Laboratories, Rancho Dominguez, CA) in 1L of diH2O for 1 day. MPs were fabricated 
from AF633 labeled HMAm as previously described [116]. After 24 hours of formation, 
aggregates were collected and volumes containing approximately 40-50 aggregates 
were chosen from each MP to cell incorporation ratio. After enzymatic dissociation of 
aggregates, MP incorporation was quantified via flow cytometry. The spatial distribution 
of fluorescently-labeled MPs within spheroids was analyzed using a LSM 700-405 
confocal microscope (Carl Zeiss, Inc). EBs fixed in 10% formalin were stained with 
Hoechst dye (1:100) for 2 hours at   ˚C followed by   successive washes in PBS prior to 
imaging. 
Gene expression analysis 
RNA was extracted from undifferentiated ESCs and EBs at days 4, 7, and 10 of 
differentiation using the RNeasy Mini Kit (Qiagen). Reverse transcription of RNA to 




was analyzed using SyberGreen technology on the MyIQ cycler (BioRad). Forward and 
reverse primer sequences for Oct4, Nanog, BrachyuryT, Flk1, Pax6, Nestin, AFP, FGF2, 
FGF5 and 18S were designed with Beacon Design software and described in Table 2. 
Gene expression was quantified with respect to levels of gene expression of 
undifferentiated ESCs and EBs without MPs or soluble HMAm supplementation. 
PCR array 
Gene  Forward Sequence  Reverse Sequence  Melt Temp  
18S CTCTAGTGATCCCTGAGAAGTTCC  ACTCGCTCCACCTCATCCTC  58.0 
Oct4  CCG GTGAGGTGGAGTCTGGAG  GCGATGTGAGTGATCTGCTGTAGG  58.0  
Nanog  GAA ATCCCTTCCCTCGCCATC  CTCAGTAGCAGACCCTTGTAAGC  58.0  
BrachyuryT  CACACCACTGACGCACAC  GAGGCTATGAGGAGGCTT TG  58.0  
Flk1  GGCGGTGGTGACAGTATC  TGACAGAGGCGATGAATGG  64.3  
Pax6  ACGGCATGTATGATAAACTAAG  GCTGAAGTCGCATCTGAG  58.0  
Nestin GGA GAA GCA GGG TCT ACA G AGC CAC TTC CAG ACT AAG G 58.0 
AFP  CACACCCGCTTCCCTCATCC  TTCTTCTCCGTCACGCACTGG  58.0  
FGF2 AGCGACCCACACGTCAAACTAC CAGCCGTCCATCTTCCTTCATA 58.0 
FGF5   58.0 
 
Histology analysis and immunostaining 
EBs were collected, fixed in 10% formalin, and embedded in Histogel (Thermo 
Scientific), processed and paraffin embedded. Paraffin embedded samples were cut into 
5 μm thick sections (Microm HM  55S). Deparaffinized sections were stained with 
hematoxylin and eosin (H&E) for basic cell morphology analysis. In addition, sections 




Aldrich) for cytoplasm, and Weigert’s hematoxylin (Sigma Aldrich) for cell nuclei or 
Alcian Blue (Sigma Aldrich) and imaged with a Nikon 80i upright microscope using the 
SPOT flex camera (15.2 64 MP Shifting Pixel, Diagnostic Instruments, Sterling Heights, 
MI). All stained sections were imaged using a brightfield microscope (Nikon Eclipse 80i). 
For whole-mount fluorescent immunostaining, formalin fixed EBs were 
permeabilized with 1.5% Triton X-100 in blocking buffer solution (2% donkey serum, 
0.1% Tween 20) for  0 minutes, followed by overnight incubation at  ˚C with primary 
antibody in blocking buffer. EBs were washed thrice with blocking buffer and then 
incubated with a secondary antibody for   hours at  ˚C. Antibodies and concentrations 
used were rabbit polyclonal, anti-Pax6 (1:50; Abcam), rabbit polyclonal anti-human 
alpha-fetoprotein (AFP) (1:200; Dako, Glostrup, Denmark), mouse monoclonal anti-rat 
Nestin (1:100; RC2, Developmental Studies Hybridoma Bank, Iowa City, IA) . EBs were 
incubated with either AlexaFluor 488 conjugated, donkey-anti-rabbit secondary 
(1:200;Invitrogen) or AlexaFluor 488 conjugated donkey-anti-mouse secondary (1:200; 
Invitrogen) and then counterstained with Hoescht (1:100) for 15 minutes at room 
temperature, washed three times with blocking buffer and imaged using a Zeiss LSM 
700-405 confocal microscope (Carl Zeiss, Inc.).  
Plating of EBs 
At day 7 of culture, a sample of EBs was collected and plated on either gelatin or 
poly-L-ornithine/laminin coated plates for 2-dimensional culture. Briefly, 0.1% gelatin 
solution (EmbryoMax, Millipore) was used to coat 24-well plates. For 
polyornithine/laminin coating, 100 μg/mL poly-L-ornithine (Sigma Aldrich) was added to 
2  well plates and incubated overnight at  7˚C. After washing with PBS,  .  μg/mL 




Finally, single EBs were pippetted with a wide bore tip (to prevent shearing of EBs) to 
individual wells to allow for cell attachment and spreading. 
Statistical Analysis 
All data are reported as mean ± standard error for a minimum of triplicate experimental 
samples. A Box-Cox power transformation was used to normalize data to a Gaussian 
distribution before performing statistical analysis. Statistical significance was assessed 
using a one-way ANOVA with Tukey’s post hoc analysis. A p-value of less than 0.05 was 
considered statistically significant. 
 
Results 
Incorporation of HMAm MPs in EBs  
HMAm MPs were incorporated within aggregates using forced aggregation at MP 
to cell seeding ratios of 1:1 and 1:3 (Figure 5.1A).  AlexaFluor 594 labeled HMAm MPs 
incorporated within ESC aggregates were identified via fluorescent and confocal 
microscopy (Figure 5.1B, Figure 5.2A). After transfer to rotary suspension culture, no 
gross morphological differences were observed in phase images of EBs with or without 
HMAm MPs. Maximum  MP incorporation within aggregates was achieved with 
approximately 970 MPs  per aggregate at a MP:cell seeding ratio of 1:1 (Figure 5.2B), 
which was used for all subsequent studies. Incorporation efficiency of MPs within 
aggregates decreased from approximately 87 to 26% as the ratio of MPs to cells 







Figure 4.1. Fluorescently labeled HMAm MPs are incorporated in ESC aggregates 
via forced aggregation. (A) HMAm MPs were incorporated within 1000-cell aggregates 
via forced centrifugation, followed by overnight incubation. After formation ESC 
aggregates were transferred to rotary culture and imaged via fluorescent microscopy. 
(B). Scale bar = 200 μm (C) HMAm MPs were incorporated within aggregates at MP to 
cell seeding ratios of 1:1 and 3:1. MPs were detected within aggregates for up to 14 









Figure 4.2. HMAm MP incorporation in ESC aggregates. (A) The presence of 
Alexafluor 594 labeled HMAm MPs throughout the aggregates was observed via 
confocal microscopy. (B) Incorporation was analyzed as a function of MP to cell seed 
ratio, with 1:1 and 3:1 incorporating similar numbers of MP per EB. (C) The efficiency of 
MP incorporation was quantified, with a MP to cell seeding ratio of 1:1. * = significant 









Analysis of growth factor concentration in spent media 
 During differentiation, ESC aggregates secrete growth factors such as BMP4, 
IGF2, and VEGF into the surrounding medium [153,154].  Additionally, previous studies 
have demonstrated that HMAm MPs can bind growth factors such as VEGF and FGF2 
with high affinity [116]. Therefore, it was hypothesized that incorporation of HMAm MPs 
could impact growth factor concentration in spent media through heparin sequestration 
of secreted factors or cell-material interactions. Analysis of growth factor concentration 
at days 4, 7, 10, and 14 of culture was measured by ELISA to determine ESC growth 
factor production. Between days 4 and 7, levels of VEGF decreased as differentiation 
progressed for EBs with and without MPs. At day 7 of culture, EBs with incorporated 
MPs demonstrated significantly (p < 0.05) higher levels of VEGF in spent media as 
compared to EBs without MPs. The detected concentration of VEGF in spent media 
continued to increase as differentiation progressed from day 7 to day 14 and remained 
similar in detection levels between groups. No detectable levels of BMP4. IGF2, or FGF2 






Figure 4.3. VEGF concentration in ESC conditioned media. VEGF concentration 
increased over the course of differentiation for both groups. At day 7 of differentiation, 
ESCs aggregates with incorporated HMAm MPs demonstrated significantly (p < 0.05) 
higher level of VEGF as compared to untreated aggregates. * = significant difference 






HMAm MP incorporation results in morphological differences in EB structure 
Histological analysis was performed on paraffin sections of day 14 ESC 
aggregates with incorporated HMAm MPs. Morphological differences were observed 
between ESC aggregate groups on day 14 of differentiation.  Aggregates treated with 
incorporated HMAm MPs and soluble HMAm exhibited increased presence of internal 
structures composed of dense cell populations as compared to untreated aggregates 
(Figure 4.4).. Safrinin-O staining was performed to identify areas of proteoglycans and 
glysaminoglycans. Areas of positive staining were observed in all groups; however, ESC 
aggregates treated with either HMAm MPs or soluble HMAm exhibited more regions of 







Figure 4.4. Histological analysis of day 14 ESC aggregates. H&E staining of Day 14 
ESC aggregates revealed the presence of more oval-shaped organized structure 
(arrows)s in  soluble HMAm and HMAm MP groups as compared to untreated 





Figure 4.5. Histological analysis of day 14 ESC aggregates. Safrinin-O staining of 
Day 14 ESC aggregates exhibited increased staining, indicative of GAG content, for 
ESC aggregates treated with either HMAm MPs or soluble HMAm as compared to 












Gene expression is modulated by HMAm MP incorporation 
Temporal gene expression for markers of pluripotency (Oct4), germ lineage 
(BrachyuryT, Flk1, Pax6, Nestin, AFP), and growth factors (FGF2 and FGF5) were 
analyzed using qRT-PCR at days 4, 7, and 10 of culture (Figure 4.6A,B).  As an 
additional control, ESC aggregates without incorporated MPs were treated with soluble 
HMAm to determine if the format of heparin presentation (i.e. outside or inside 
aggregates) to cells had an effect on gene expression. The total amount of added 
soluble HMAm corresponded to the total amount of HMAm MP incorporated within EBs 
at day 0. Soluble HMAm was added after each media exchange to replenish soluble 
HMAm removed and to maintain the same HMAm concentration as EBs with 
incorporated MPs. As expected, expression of Oct4 decreased over the entire course of 
differentiation for all groups and no significant differences were observed between any 
groups (Figure 4.6C). No significant differences were observed between any groups for 
FGF5 (growth factor), BrachyuryT (mesoderm), and Nestin (neuroectoderm). Expression 
of Flk1 (mesoderm) was significantly (p < 0.05) increased for soluble HMAm treated 
aggregates, while expression of FGF2 (growth factor) was significantly (p < 0.05) 
decreased for HMAm MP aggregates at day 10 as compared to untreated aggregates 
(Figure 4.6C). Multiple differences were observed for endoderm marker, AFP, and 
ectoderm marker, Pax6, between groups (Figure 4.6C).  Expression of AFP in 
aggregates treated with soluble HMAm was up-regulated by almost 4 fold  at day 7 as 
compared to untreated and HMAm MP aggregates. Additionally, soluble HMAm treated 
aggregates exhibited increased (3.52 fold) AFP expression as compared to HMAm MP 
aggregates at day 10.  At day 4 of differentiation, expression of Pax6 for HMAm MP 
aggregates was significantly down-regulated  for both untreated (- 0.81 fold and soluble 




Pax6 expression as at day 7 and 10, while HMAm MP aggregates demonstrated 
increased Pax6 expression at day 10 as compared to untreated group aggregates. 
 
Figure 4.6.  Incorporation of HMAm MPs modulates ESC differentiation.  (A) HMAm 
MPs were incorporated within ESC aggregates and cultured for 10 days in rotary 
suspension culture. ESC aggregates were also treated with soluble HMAm to compare 
different formats of heparin presentation to cells. No gross morphological changes were 
observed between groups. (B) Expression of Oct4 for all groups decreased over the 
course of differentiation (days 4, 7, and 10). Pax6 expression was modulated by 
treatment with both soluble HMAm and HMAm MPs, whereas AFP expression was only 
modulated in the presence of soluble HMAm. FGF expression at day 14 for ESC 
aggregates with MPs was increased as compared to untreated aggregates. * = 






Protein expression is altered by HMAm MP incorporation 
 Whole-mount immunofluorescent staining was performed on Pax6 (ectoderm) 
and AFP (endoderm) in ESC aggregates at day 7 and 10 as differences in gene 
expression were almost exclusively found in ectoderm and endoderm markers at these 
time points. During embryogenesis, Pax6 is a key transcription factor that plays a role 
during early development of the central nervous system and is expressed in radial glial 
cells upon neuroectoderm formation [155]. Therefore, as ESC aggregates cultured under 
serum free conditions more readily differentiate to neuroectoderm, protein expression of 
Pax6 was investigated. Positive Pax6 expression was observed throughout ESC 
aggregates for all three groups at day 7 of culture (Figure 4.7). However, EBs treated 
with soluble HMAm and HMAm MPs exhibited more abundant fluorescent 
immunostaining for Pax6 as compared to untreated aggregates. Pax6 expression at day 
10 was only observed in untreated and soluble HMAm treated groups.  In contrast to day 
7, Pax6 expression decreased and was primarily observed in untreated and soluble 
HMAm aggregates. Positive expression of endoderm marker, AFP, was observed 
throughout aggregates at day 7 in soluble HMAm and HMAm MP groups, but AFP 
expression was not observed in day 7 untreated aggregates or for all groups at day 10 
(Figure 4.8). At day 7, aggregates from each group were further cultured for an 
additional 7 days on poly-L-ornithine/laminin coated 24-well plates. At day of 14 of 
differentiation (7 days after plating), EBs from each group exhibited a dome-shaped cell 
body with extension of neurites from the edges of the aggregates (Figure 4.9) 
Immunostaining for Nestin expression in plated EBs was performed after 14 total days of 
differentiation.  Nestin, an intermediate filament, is a marker of neural precursor cells 
(NPCs) in embryonic tissues and plays a role in the radial growth of axons [155,156]. 
Analysis of plated EBs demonstrated that all groups expressed Nestin, primarily located 




with soluble HMAm and HMAm MPs exhibited more pronounced filamentous staining for 
Nestin as compared to untreated aggregates, suggesting that heparin enhances ESC 




















Figure 4.7.  Pax6 expression in ESC aggregates is modulated with HMAm 
treatment. At day 7 and 10 of differentiation, spatial distribution of Pax6 expression 
within ESC aggregates was observed via fluorescent immunostaining. Positive 
expression of Pax6 was observed throughout aggregates for all groups at day 7, with 
more abundant expression observed in soluble HMAm and HMAm MP groups. By day 
10, little expression of Pax6 was observed for HMAm groups, while positive expression 
was localized to specific regions within aggregates for untreated and soluble HMAm 













Figure 4.8.  AFP expression in ESC aggregates is modulated with HMAm 
treatment.  Immunostaining for endoderm marker, AFP, was performed on day 7 and 10 
ESC aggregates. Positive AFP expression was observed in ESC aggregates treated 
with soluble HMA or with HMAm MPs at day 7. No expression of AFP was observed for 








Figure 4.9 Phase images of ESC aggregates plated on poly-L-ornithine/laminin 
after 14 days of culture.  ESC aggregates cultured for 7 days in suspension were 
retrieved and plated on poly-L-onrithine/laminin. After culturing for an additional 7 days, 
EBs exhibited a domed ovoid morphology with extension of neurites (arrows) from the 






Figure 4.10  Nestin expression of plated ESC aggregates. At day 7 of differentiation, 
ESC aggregates were plated on poly-L-ornithine/laminin coated 24-well plates and 
cultured for an additional 7 days. Staining for Nestin was performed after 14 total days of 
differentiation.  All groups contained Nestin+ cells that were primarily found near the 
exterior of ESC aggregates, indicative of neural precursor cells. Aggregates treated with 
either soluble HMAm or HMAm MPs demonstrated distinct filamentous Nestin staining 















The incorporation of heparin-methacrylamide (HMAm) MPs within ESC aggregates 
demonstrated of the utility of exogenous GAGs as in vitro modulators of cell fate 
decisions and  can alter the differentiation outcomes of ESCs. Previous studies have 
incorporated MPs of various materials to alter patterns of differentiation of ESCs in 
media supplemented with serum, an undefined mixture of proteins [121,127]. While 
serum promotes meso- and endoderm differentiation in ESCs, serum-free conditions 
enhance ESC differentiation toward neuroectoderm [33,157]. In addition, serum-free 
culture provides a system that is more amenable to outside manipulation and direct 
investigation of MP material effects on cell behavior, an important advantage as heparin 
plays a role in the coordination of various signaling pathways by regulating the activity of 
multiple different biomolecules [68,158]. Ultimately, the role of heparin on ESC behavior 
can be examined by minimizing external influences such as serum or addition of a 
cocktail of factors typically used in stem differentiation strategies [9,10,131,159]. 
Previously, incorporation of heparin-gelatin MPs (Lassahn & Bratt-Leal et al. 
unpublished) has been investigated under serum-free conditions to analyze ESC 
differentiation, providing motivation for the use of GAG-based MPs to alter ESC growth 
factor production and modulate EB differentiation. 
 The addition of soluble heparin to stem cell cultures has been previously 
investigated to examine the effect of GAGs on ESC differentiation. Addition of heparin to 
EBs was shown to enhance hematopoietic differentiation [80], while heparin 
supplemented to adherent ESC cultures enhanced differentiation toward Sox1+ neural 
progenitor cells [160].  However, frequent media exchanges during cell culture involve 
the repeated supplementation of exogenous GAGs, resulting in the removal of  any 




concentrates endogenous heparin-binding growth factors within EBs. Analysis of 
heparin-binding growth factors present in spent media was investigated to determine 
whether HMAm MPs modulate secreted growth factor concentration. For example, 
heparin/HS are known to bind FGF2, which plays a role in ESC differentiation toward 
ectoderm, and are critical in the formation of the FGF-FGFR complex [62].  However, 
only VEGF was detected, while levels of BMP4, IGF2, and FGF2 were below limits of 
detection (15 pg/mL). Due to low abundance of growth factors present, further 
investigation of the morphogen profile present in conditioned media could be 
investigated using mass spectrometry analysis [161], buy may require additional steps to 
concentrate protein for detection. Additionally, separation of MPs from EBs could be 
performed for direct analysis of growth factor bound MPs, ultimately providing more 
information about what MP-growth factor interactions occur during EB differentiation. 
Previous studies have demonstrated that soluble heparin enhanced FGF signal 
transduction, by concentrating FGF near cell surface receptors [62,160]. Therefore, 
activation of specific signaling pathways (e.g. BMP or FGF) that regulate ESC exit from 
self-renewal could be analyzed using Western Blot analysis or other sentinel ESCs with 
fluorescent reporters that respond with specificity to retinoic acid, activin A, Wnts, or 
Notch [145]  to determine the effect of HMAm MPs on signaling activity. 
 During neuronal differentiation of ESCs, neuroectoderm formation is 
characterized by expression of Sox1, followed by expression of Pax6 as cells transition 
to radial glia and mature neurons  [155,162]. Analysis of Pax6 expression in ESC 
aggregates with incorporated HMAm MPs or treated with soluble HMAm more abundant 
staining for protein expression at day 7 and upregulation of gene expression over the 
course of differentiation suggesting that heparin may enhance neuroectodermal 
differentiation through sequestration of specific factors produced by ESCs,. However, 




mesoderm (Flk1) and endoderm (AFP) markers as compared to aggregates with 
incorporated MPs, suggesting that the format of heparin presentation to EBs plays a role 
in directing ESC differentiation. Diffusion of soluble HMAm (18 kDa) within EBs is most 
likely restricted by the formation of a dense outer cell layer [132,163], thus preventing 
uniform distribution of heparin within aggregates and limiting cell-heparin interactions to 
primarily with cells on the exterior. In contrast, incorporation of HMAm MPs allows for 
distribution of heparin throughout EBs and results demonstrate that MPs are retained 
within aggregates for up to 14 days. Furthermore, soluble HMAm may sequester factors 
produced by aggregates away from cell surface receptors and is also removed during 
media exchanges, which could disrupt activation of specific signaling pathways.  After 
plating of EBs, Nestin, a marker for neuroepithelial cells [33,164], was detected in all 
groups; however, further characterization of neurite outgrowths (e.g. number and 
length), can be performed by analyzing fluorescence microscopy images of EBs stained 
for neurite marker, TuJ1 (neuron-specific class III β-tubulin) or neurofilament, using 
image processing techniques to further examine the ability of HMAm MPs to enhance 





HMAm MPs provides a novel tool to influence the differentiation of ESCs by 
presenting natural GAG-based materials within 3D morphogenic environments. Pax6 in 
response to HMAm MP incorporation within ESC aggregates demonstrated upregulation 
of gene expression and more pronounced fluorescent immunostaining Pax6, a marker of 
early neuroectoderm, suggesting that HMAM MPs can alter differentiation outcomes of 
EBs, most likely by sequestration and concentration of endogenous morphogens within 




new class of biomaterials capable of capturing stem cell derived morphogens in a 
biomimetic manner to yield more efficient approaches for directed stem cell 
differentiation and demonstrate the utility of GAG MPS as a complement to growth factor 








PROTEOMIC ANALYSIS OF EMBRYONIC STEM CELL 




ESCs spontaneously differentiate during in vitro culture, when pluripotency 
maintaining components such as MEF feeder layers or LIF are removed, synthesizing a 
complex array of various factors and soluble cues that direct cell fate. Moreover, 
signaling molecules that direct tissue patterning during embryonic development are 
secreted by ESC aggregates, known as embryoid bodies (EBs), which emulate aspects 
of morphogenesis observed during embryonic development [48,129].  EB models 
provide an attractive in vitro platform from which cells of specific developmental stages, 
including vasculogenesis [48], osteogenesis [103] , and neurogenesis [167], can be 
enriched and analyzed for morphogen expression. Interestingly, evidence suggests that 
biomolecules synthesized by ESCs can play an important role in regenerative events 
observed in vivo [168–171]. However, transplantation of ESCs is limited due to risk of 
tumor formation and immune response and attempts to administer bolus injections of 
ESC-derived morphogens, such as from conditioned media, are insufficient for localized 
and sustained delivery of morphogens.  
 Extracellular matrix (ECM) components, such as glycosaminoglycans (GAGs), 
play crucial roles in cell signaling and regulation of morphogen gradients during early 
development through binding and concentration of secreted growth factors, thus 




to conjugation of highly sulfated GAGs, such as heparin, provide ideal matrices for 
manipulation and efficient capture of ESC morphogens via reversible electrostatic and 
affinity interactions. In particular, engineered microparticles (MPs) have been extensively 
used as delivery vehicles for sustained release of morphogens [121,124–126,173]. 
Therefore, MPs synthesized from heparin-methacrylamide (HMAm) can be used as a 
tool to concentrate and localize ESC morphogens [116]. Ultimately, biomaterials 
designed to efficiently capture and retain bioactive ESC-derived morphogens offer an 
attractive platform to translate the regenerative potential of ESCs into molecular 
therapies.  
 Previously, mass spectrometry (MS) approaches have been employed to 
globally analyze the proteomics of ESC secretomes. Identification of the most abundant 
proteins present in samples are typically analyzed by liquid chromatography coupled to a 
mass spectrometer (LC-MS/MS), where most abundant proteins are preferentially 
selected for MS/MS fragmentation. However, low abundance and concentration of 
secreted proteins of interest significantly limits the success of MS analysis. Previous 
studies have employed strategies to pre-fractionate and enrich protein samples by 
performing techniques such as SDS-PAGE and organelle isolation to obtain a temporal 
snapshot of proteins secreted during stem cell differentiation [161,174–177]. This work 
proposes to develop a novel strategy to capture secreted ESC morphogens in a 










BMP4 and conditioned media loading of HMAm MPs 
HMAm MPs were resuspended in PBS and MP concentration was determined 
using a hemacytometer. Prior to growth factor loading, MPs were freeze-dried using a 
lyophilizer (Labconco, Kansas City, MO). Conditioned (or spent) media was collected 
from EB culture at days 4, 7, 10, and 14 of differentiation. Lyophilized MPs were added 
to human recombinant bone morphogenetic factor 4 (hBMP4) diluted in a 1% BSA 
solution or conditioned media and incubated overnight at  ˚C to facilitate growth factor 
binding. MPs with bound growth factor were washed three times in PBS to remove any 
loosely bound protein. MPs not used immediately after growth factor incubation were 
stored at -20˚C to preserve protein bioactivity and prevent degradation.  
SDS-PAGE and silver staining 
Samples of growth factor bound MPs were prepared by mixing samples in  2 μL 
PBS with 8 μL of 5x diluted loading buffer (1.25 mL 0.5 M Tris-HCL (pH 6.8), 1 g SDS, 5 
mL glycerol, 5 mg Bromophenol Blue, 1.25 mL β-mercaptoethanol) and heating for 10 
minutes at 95˚C. Samples of growth factor bound microparticles were added to wells of 
gel and growth factor separation was resolved on a 12% or 4-15% mini-PROTEAN® 
TGXTM gel (Bio-Rad, Hercules, CA) at 200V for 30 minutes. A KaleidoscopeTM (Bio-Rad, 
Hercules, CA) protein ladder was used to indicate molecular weight of bands. For 
conditioned media samples,  2 μL of spent media was added to 8 μL of loading buffer 
prior to loading into the wells. 
The Silver Stain Plus kit (Bio-Rad, Hercules, CA) was used to visualize protein 
present in the gel. Briefly, gels were fixed in 50% methanol, 10% acetic acid, and 10% 
fixative enhancer concentrate for 40 minutes on an orbital shaker. Gels were washed 




appearance of dark bands (approximately 20-40 minutes). The reaction was stopped by 
adding 5% acetic acid for 15 minutes. 
Fluorescamine assay 
A fluorescamine assay was used to assay the amount of protein bound to HMAm 
microparticles. Fluorescamine reacts with primary amine groups found in terminal amino 
groups to form fluorescent pyrrolinone type moieties for protein quantification HMAm 
MPs (0.5 mg) were added to 1, 5, and 10 mL of conditioned media and incubated 
overnight at  ˚C. HMAm microparticles were washed  x in PBS to remove loosely bound 
protein. SDS-PAGE Loading buffer was added to one-half of the samples and heated at 
95˚C for 10 minutes to promote dissociation of MP bound growth factors through protein 
denaturation and charge neutralization.  SDS and heat treated samples were washed 3x 
again in PBS. All samples were subsequently reacted with 0.01% w/v fluorescamine 
solution (1.84 mg in 18.4 mL acetone) at room temperature and immediately read on a 
Synergy H4 microplate reader (Biotek, Winooski, VT) at excitation of 390 nm and 
emission of 475 nm. The number of free amine groups present on growth factor bound 
MPs was determined using a glycine standard curve (0.05 – 8 μg/mL) and compared to 
unloaded MPs and MPs treated with SDS and heat. 
Conditioned media protein extraction and digestion 
Bands were cut from gel into 1 mm2 pieces and 200 μL 50% acetonitrile (ACN) 
and 50% 50 mM NH4HCO3 were added, followed by vortexing the sample for 5 minutes. 
Supernatant solution was removed and 200 μL 50% acetonitrile (ACN) and 50% 50 mM 
NH4HCO3 was added again to excised bands for 10 minutes at room temperature. 
Supernatant was removed and gel pieces were dried in a speed vacuum for 10 minutes. 
Samples were placed on ice and either trypsin in 50 mM ammonium bicarbonate or Glu-




added the next day to samples treated with Glu-C and samples were incubated for an 
additional 4 hours at  7˚C. Protein digestion was quenched with 0.1% formic acid until 
the pH reached 2. Finally, LC-MS/MS analysis and database search was performed as 
described before with the following changes: The HPLC gradient was a 30 minute 
gradient of 5-100% ACN containing 0.125% FA. All MS/MS spectra were searched 
against a database that included sequences of all proteins in the UniProt Mouse (Mus 
musculus) Database Samples digested with NTCB searched with a parameter file listing 
the following differential modifications: oxidation of methionine (+15.9949); and one fixed 
modification of carbamidomethylation of cysteine (+57.0214) [178]. 
HMAm MPs retrieval from EBs 
Separation of HMAm MPs from EBs was performed by non-enzymatic 
dissociation of EBs, followed by a Percoll density gradient centrifugation. EBs with 
incorporated HMAm MPs were collected from suspension culture in 15 mL conical tubes 
and allowed to settle by gravity sedimentation to the bottom. EBs were washed 3x in 
PBS and incubated in 1 mL of non-enzymatic Gentle Cell Dissociation Reagent 
(StemCell Technologies, Vancouver, BC) to prevent digestion of MP bound protein for 
20 minutes at  7˚C. Dissociation of EBs was aided by gentle pipetting of EBs during 
incubation in dissociation buffer. Dissociated EBs and HMAm MPs were centrifuged at 
1,000 RPM and washed with PBS for three rounds. Percoll gradient was formed as 
described previously for separation of dissociated cells and MPs [1].  Briefly, Percoll 
(Sigma Aldrich) was mixed with 8.5% NaCl (9:1) and diluted to 40.5 and 58.5%, which 
correspond to a physical density of 1.065 and 1.069 g/mL. Three mL of 58.5% Percoll 
was added to the bottom of a 15-ml conical tube, followed by adding 3 ml of 40.5% 
Percoll on top.  Finally, 3 ml of the dissociated cells and MPs were added on top of the 




centrifugation at 1,500 RPM for 30 minutes. After centrifugation, the top, 40.5%, and 
58.5% layers were separated into different conical tubes by pipetting. Each fractions was 
washed twice in PBS and quantification of efficiency of MP and cell separation was 
perfomed using an AccuriTM C6 flow cytometer (BD Biosciences, San Jose, CA). Flow 
cytometry was performed on control samples of only dissociated cells or MPs to 
determine gating for Percoll fractions. Each Percoll layer (top, 40.5%, and 58.5%) were 
analyzed and gated based on control samples.   
Statistical Analysis 
All data are reported as mean ± standard error for a minimum of triplicate 
experimental samples. A Box-Cox power transformation was used to normalize data to a 
Gaussian distribution before statistical analysis. Statistical significance was assessed 
using a one-way ANOVA with Tukey’s post hoc analysis. A p-value of less than 0.05 was 
considered statistically significant. 
 
Results 
Characterization of BMP4 release from HMAm MPs using SDS-PAGE 
Initial experiments to determine the potential of using gel electrophoresis for 
removal of MP bound protein for characterization were carried out using recombinant 
human BMP4 (Figure 5.1A). BMP4 is a well-known heparin-binding protein [86,179] and 
also known to be present in ESC conditioned media [154], thus providing a “model” 
protein for SDS-PAGE analysis of MP bound growth factors.  SDS-PAGE and silver-
staining were performed on gels with HMAm MPs loaded with 10 ng of hBMP4, soluble 
hBMP4 and unloaded HMAm MPs (Figure 5.1B). The electrostatic interaction between 




loading into gel. The intensity of staining for BMP4 released from HMAm MPs was 
compared to soluble BMP4 to observe the efficiency of gel electrophoresis to dissociate 
growth factors from MPs. Since, hBMP4 (loaded and soluble) was diluted in 1% BSA, 
stained bands were observed at 66kDa and between 22-25 kDa for both BSA and 
hBMP4, respectively. For soluble hBMP4, bands for BSA were darker and larger in size 
as compared to BMP4 loaded on HMAm MPs (Figure 5.1A). In addition, staining was 
also darker for soluble hBMP4 as compared to BMP4 loaded MPs, indicating that BMP4 
was not completely released from MPs.  Unloaded MP lanes did not demonstrate any 
staining, indicating that direct loading of MPs in PAGE gels does not interfere with gel 
electrophoresis or silver staining.  
  The release of hBMP4 from HMAm MPs via SDS-PAGE was further investigated 
by increasing the duration in which loaded MPs were heated prior to gel loading (Figure 
5.1C). More staining was observed for BMP4 loaded MPs when the duration of heating 
at 95˚C was increased from 5 to 10 and 15 minutes. Similarly, staining for hBMP  for 
soluble hBMP4 groups also improved with increased heating times. However, hBMP4 
staining was still greater for soluble hBMP4 as compared to hBMP4 loaded MPs. 
Interestingly, staining for bands at 50 kDa appeared for both soluble hBMP4 and hBMP4 







Figure 5.1. SDS-PAGE can be used to detect MP bound protein.  A) HMAm MPs 
were loaded overnight incubation in either a BMP  solution or conditioned media at  ˚C. 
Protein loaded MPs are treated with SDS and heat prior to performing SDS-PAGE. B) 
MPs loaded with 10 ng of BMP4 demonstrate decreased staining for BSA and BMP4 at 
66 and 25 kDa, respectively, as compared to soluble control. C)  Improved staining for 
BMP4 was observed by increasing the duration time from 5 to 10 or 15 minutes in which 







Concentration and characterization of ESC CM bound to HMAm MPs 
Analysis of conditioned media via gel electrophoresis was insufficient to detect 
pico- and nanogram levels of protein as silver staining resulted in the presence of dark 
and smeared bands due to large quantities of BSA present (Figure 5.2A).  To detect 
pictogram levels of protein, staining time was increased from 15 minutes to 30 minutes; 
however, staining of BSA ultimately limited detection of proteins lower in molecular 
weight and abundance.  As previously described, HMAm MPs were observed to limit 
binding of BSA (pI=4.7) while simultaneously presenting a means to concentrate 
conditioned media. BSA levels of varied dilutions of conditioned media were compared 
to HMAm MPs loaded with 1 and 5 mL of media (Figure 5.2B). Total volume of 
conditioned media used for 1x, 5x, 10x, and 25x dilutions were  2, 6. ,  .2, and 1.28 μL, 
respectively. Increasing the dilutions of media decreased the presence of BSA, but also 
limited the detection of other proteins. Conversely, HMAm MPs loaded with 1 and 5 mL 
of conditioned media demonstrated levels of BSA similar to the 25x diluted media, but 
were able to enhance detection of low molecular weight proteins (Figure 5.2C). More 
specifically, MPs demonstrated approximately 20x less BSA binding when compared to 
undiluted conditioned media. Additionally, HMAm MPs loaded with 5 mL of conditioned 
media showed darker staining as compared to MPs loaded with 1 mL of media, 
indicating more binding of protein with increased volume of media. 
Further characterization of the use of MPs to concentrate conditioned media was 
performed by comparing HMAm MPs to MPs composed of other polymer types, such as 
gelatin-methacylate (GMA) [118], chondroitin-sulfate (CSMA) [117], and heparin-
functionalized polystyrene (Hep-PS) beads (Figure 5.3).  Overall, all MPs demonstrated 
staining for similar bands, but the intensity of bands differed among groups, suggesting 
that the different MPs bound proteins from conditioned media with variable affinities. 




increased staining for BSA as compared to CSMA and HMAm MPs and demonstrated 
less intense staining for other protein bands, most notably at 50, 35, and 17 kDa for both 
0.1 and 0.5 mg of MPs (Figure 5.3; white arrows). Hep-PS MPs demonstrated the least 
intense staining for all protein bands below 60 kDa, yet showed darker staining for BSA 
as compared to all other MPs. In addition, Hep-PS required a greater amount of MPs (1 
and 2 mg of MPs) as compared to other MP types (0.1 and 0.5 mg of MPs) in order to 
visualize stained bands of protein. In contrast to HMAm MPs, which were composed 
solely of heparin, Hep-PS MPs were composed of heparin-functionalized to the surface 
of polysystrene beads, which limited the total amount of growth factor binding. To 
decipher if protein binding was dependent on species of GAG, CSMA MPs were also 
compared to HMAm MPs. CSMA MPs demonstrated similar staining profile toHMAm 
MPs at both MP amounts (0.1 and 0.5 mg of MPs) (Figure 5.3). Unlike the differences 
observed between 0.1 and 0.5 mg of GMA MPs for protein staining, no differences were 
observed between different CSMA and HMAm MP quantities (0.1 and 0.5 mg), 
suggesting that GMA MPs bind less total protein per mg MP as compared to GAG-based 
MPs.   





Figure 5.2. HMAm MPs can be used to concentrate ESC conditioned media. A) 
SDS-PAGE was performed on unloaded conditioned media. Due to large quantities of 
BSA (red box) present in media, staining of BSA was smeared across the gel and 
masked bands for protein at lower molecular weights. B) Conditioned media at 1, 5, 10, 
and 25x dilutions were compared to MPs loaded with 1 mL and 5 mL conditioned media. 
Conditioned media (1 and 5 mL) loaded MPs showed similar staining levels for BSA 
(pI=4.7) (white arrows)  as the 25x diluted CM and similar staining levels for other 
proteins as the 1x diluted CM, indicating that MPs are able to effectively concentrate 
conditioned media and limit binding of BSA. C) ImageJ software was used to measure 
the relative levels of intensity of BSA staining for each group, where the highest value 
was measured for 1x conditioned media and the lowest value was observed for both 





Figure 5.3. HMAm MPs demonstrate higher protein binding as compared to other 
MP formulations.   SDS-PAGE was performed on MPs synthesized from different 
polymer types to compare differences in binding of protein from conditioned media. Both 
GAG-based MPs (CSMA and HMAm) demonstrated the darkest staining of protein 
bands, as well as the least staining for BSA (66 kDa) (red box).  In contrast, GMA MPs 
showed similar protein bands but with decreased intensity of staining, especially at 0.1 
mg of MPs. Hep-PS MPs showed decreased staining for all protein bands and required 
much larger quantities of MPs to visualize protein bands.  Both GMA and Hep-PS MPs 
had increased staining of BSA as compared to CSMA and HMAm MPs, suggesting that 
GAG based MPs limit binding of BSA over other MP types. White arrows represent 












 Mass spectrometry analysis of gels loaded with MP bound protein. 
MS analysis was performed on excised bands of interest from gels to 
characterize the profile of protein bound to HMAm MPs. Table 5.1 provides an overview 
of all experiments performed and parameters altered to develop a suitable method for 
protein characterization. Briefly, MS analysis was performed on stained or unstained 
gels with conditioned media or growth factor (hBMP , hBMP2, and hTGFβ1) loaded 
MPs. Many silver staining protocols are not compatiable for MS analysis due to 
crosslinking and fixing of gels prior to staining, preventing enzymatic digestion of protein 
[180]. Therefore, identification of peptides was compared between unstained and 
stained gels; however, results demonstrated no differences between gels. Additionally, 
multiple enzymes were used for protein digestion of excised bands from gels. Typically, 
peptides between 7 and 20 amino acids (AAs) in length are ideal for MS analysis and 
database searching [181]. For example, with trypsin digestion, BMP2 generates 1 
peptide, while TGFβ generates   peptides between 7-20 AAs. Therefore, using a 
combination of enzymes, such as GLu-C and Lys-C, theoretically generates more 
peptides of ideal length [182]  Unexpectedly, the majority of peptides identified by MS 
were intracellular proteins such as histones, ribosomal proteins, actin, etc.  
In an attempt to limit the amount of contamination of intracellular proteins 
released from cells into the collected spent media, MPs loaded with freeze-thawed 
samples of conditioned media were compared to conditioned media collected fresh from 
ESC cultures (Figure 5.5A). A BCA protein assay was performed on fresh and freeze-
thawed CM to determine if protein concentration increased due to lysed cells in thawed 
CM. However, no detectable differences between protein concentrations were observed 
via a BCA assay (Figure 5.4B). Conversely, staining of the gel saw more staining of 
specific bands at 30 kDa and 15 kDa for frozen conditioned media. However, results 




Table 5.2 presents a typical list of proteins often detected from MS analysis of excised 
bands from gels with conditioned media loaded MPs. A wide variety of proteins were 
detected and widely distributed across the gel such as ribosomal proteins (9- 35 kDa), 


























Table 5.1: Summary of mass spectrometry studies. 
Experiment 
Description 
Run on gel Mass Spec Method 
(enzymes, database, 
exclusion of  
specific peptides 
Results 
CM loaded MPs Yes Standard gel digestion method with 
trypsin (see next slide) 
Histones, tubulin, ribosomal 
proteins, thrombospondin, FGF4, 
other intracellular proteins 
CM/BMP4 loaded MPs 
(staining under laminar 
flow hood) 
Yes Standard gel digestion method with 
trypsin 
Keratin contaminants, histones, 
ribosomal proteins, actin, other 
intracellular proteins 
Unloaded BMP4 solution 
(1.25 ug) 
No Adjust pH to 8.5 with NH4HCO3 
Add trypsin. Incubate overnight 37 deg. 
Quench and stage tip; MS analysis 
Detected only BMP2 
Lyophilized protein 
samples hBMP4 (40 ng) 
hBMP2 (95ng) 
hVEGF (50 ng) 
mIGFII (65ng) 
No Add NH4HCO3, and trypsin. Incubate 
overnight 37 deg. Quench and stage tip; 
MS analysis 
No peptide hits due to high presence 
of detergents 
Unstained gel) – 
BMP4/CM loaded MPs 
Yes Standard gel digestion method with 
trypsin 
Several intracellular proteins (as 
above), BMP4 was not identified. 
Unloaded protein solution 
hTGF-β (2ug) 
BMP2 (35 ug/ml – 20/40 
ul) 
No Adjust pH to 8.5 with NH4HCO3 
Add trypsin. Incubate overnight 37 deg. 
Quench and stage tip; MS analysis 
Only identified BSA 
Unloaded protein solution 
hTGF-β (2ug) 
BMP2 (35 ug/ml – 20/40 
ul) 
No Reduction & alkylation (5 mM DTT, 14 
mM IAA) 
Add PBS pH=8 and Glu-C. Incubate 
overnight 37 deg. Add Lys-C, incubate 4 
hr.  Quench and stage tip; MS analysis 
Successfully identified proteins 
Unstained gel-, MP 
loaded protein of  
hTGF-β 
BMP2 
Yes Standard gel digestion method with Glu-
C and Lys-C 
BMP2 was identified, but not TGF-β, 
on stained half of gel. Neither 
identified on unstained half. 
CM loaded MPs Yes Standard gel digestion method 
Lanes 1 and 3 – trypsin 
Lanes 2 and 4 – Glu-C, Lys-C  
Several intracellular proteins (as 
above) 
Direct analysis of BMP4  
(50 ng) loaded on MPs 
No Remove solution, add 50 mM NH4HCO3 
(pH=8.5) and trypsin. Incubate overnight 
37 deg. Quench and stage tip; MS 
analysis 
Only detected contaminants 
Frozen CM versus fresh 
CM 
Yes Standard gel digestion method 
Lanes 1 and 3 – trypsin 
Lanes 2 and 4 – Glu-C, Lys-C 
Several intracellular proteins (as 
above), no differences between 






Figure 5.4. SDS-PAGE analysis of fresh versus frozen conditioned media loaded 
on HMAm MPs. A)  Conditioned media that underwent 1 freeze thaw cycle 
demonstrated increased staining of bands at 15 and 30 kDa as compared to fresh 
conditioned media that has not been previously frozen.  B) No significant difference 
between the total protein concentration of fresh and frozen CM was observed after 



















Table 5.2. Summary of MP bound proteins detected by mass spectrometry 
analysis.* 
 
Unique Total AVG Annotation 
5 6 3.7722 HSP7C_MOUSE Heat shock cognate 71 kDa protein 
4 6 3.3626 ENPL_MOUSE Endoplasmin 
4 4 3.0904 HMGB1_MOUSE High mobility group protein B1 
4 4 2.8959 K1C16_HUMAN_contaminant Keratin, type I cytoskeletal 16 
3 5 2.7105 NUCL_MOUSE Nucleolin 
3 4 4.0219 TRYP_PIG_contaminant Trypsin 
3 4 3.8079 RDRP_SCVLA_contaminant Probable RNA-directed RNA polymerase 
3 4 3.1856 K2C8_HUMAN_contaminant Keratin, type II cytoskeletal 8 
3 4 3.0954 RSMB_MOUSE Small nuclear ribonucleoprotein-associated protein B 
3 4 2.8068 VDAC1_MOUSE Voltage-dependent anion-selective channel protein 1 
3 4 2.7604 ATPA_MOUSE ATP synthase subunit alpha, mitochondrial 
3 3 3.7016 NACAM_MOUSE Nascent polypeptide-associated complex subunit 
alpha, muscle-specific form 
3 3 3.024 HMGB2_MOUSE High mobility group protein B2 
3 3 2.7908 HS90A_MOUSE Heat shock protein HSP 90-alpha 
3 3 2.7234 K1C14_HUMAN_contaminant Keratin, type I cytoskeletal 14 
3 3 2.6782 RU2A_MOUSE U2 small nuclear ribonucleoprotein A' 
3 3 2.5869 FETUA_BOVIN_contaminant Alpha-2-HS-glycoprotein 
3 3 2.5362 H12_MOUSE Histone H1.2 
2 3 3.7284 TBA1B_MOUSE Tubulin alpha-1B chain 
2 3 2.9373 GRP78_MOUSE 78 kDa glucose-regulated protein 
2 3 2.8676 MBB1A_MOUSE Myb-binding protein 1A 
2 3 2.5755 DCD_HUMAN_contaminant Dermcidin 
2 2 3.6608 ALBU_HUMAN_contaminant Serum albumin 
2 2 3.4969 RS8_MOUSE 40S ribosomal protein S8 
2 2 3.4223 K1C18_HUMAN_contaminant Keratin, type I cytoskeletal 18 
2 2 3.1555 TSP1_MOUSE Thrombospondin-1 
2 2 3.1495 Q792Z1_MOUSE MCG140784 
2 2 3.1471 RL18_MOUSE 60S ribosomal protein L18 
2 2 3.1436 K2C6C_HUMAN_contaminant Keratin, type II cytoskeletal 6C 
2 2 2.9332 VIME_MOUSE Vimentin 
2 2 2.887 RS4X_MOUSE 40S ribosomal protein S4, X isoform 
2 2 2.855 RL7A_MOUSE 60S ribosomal protein L7a 
2 2 2.8118 AT1A1_MOUSE Sodium/potassium-transporting ATPase subunit alpha-
1 
2 2 2.6684 RS3_MOUSE 40S ribosomal protein S3 
2 2 2.6157 KPYM_MOUSE Pyruvate kinase PKM 
2 2 2.5392 TBB5_MOUSE Tubulin beta-5 chain 
2 2 2.5067 SAHH_MOUSE Adenosylhomocysteinase 
2 2 2.436 EF1A1_MOUSE Elongation factor 1-alpha 1 
2 2 2.425 APOE_MOUSE Apolipoprotein E 
2 2 2.1744 H15_MOUSE Histone H1.5 
*The "unique" column is the unique number of peptide hits for the specific protein in the run, while the "total" 





Direct characterization and quantification of MP bound protein 
To ensure that proteins being eluted effectively by electrophoresis and SDS, a 
fluorescamine assay was performed to quantify protein bound to MPs after loading of 1, 
5, or 10 mL of conditioned media (Figure 5.5).. Total protein after treatment with SDS 
and heat was also quantified to determine the efficacy of protein dissociation from 
HMAm MPs. Baseline values for unloaded MPs (~9.79 ug/mg MP) were subtracted from 
all other experimental groups prior to calculating MP bound protein concentration. 
Approximately  .9 ± 1. , 8.  ± 0.5, and 10.5 ± 1.1 μg of free amines per 0.5 mg MPs 
were detected for MPs loaded with 1, 5, and 10 mL of conditioned media, respectively. 
MPs loaded with 5 and 10 mL conditioned media demonstrated significantly more 
detection of free amines than MPs loaded with 1 mL of media.  For MPs treated with 
SDS at 95˚C for 10 minutes, approximately 0.1 ± 0.1, 0.  ± 0.2, and 0.8 ± 0.  μg/mL free 
amines were detected for 1, 5, and 10 mL of conditioned media, respectively, indicating 
that SDS/heat treatment promotes protein dissociation from MPs.  All groups treated 











Figure 5.5: SDS and heat treatment reduces detection of protein bound to HMAm 
MPs.  Detection of free amines was significantly (p < 0.05) lower for all groups after 
treatment with SDS and heat, with less than 1 ug of free amines per 0.5 mg MP detected 
and more than 90% of protein removed as compared to untreated samples.  Both MP 
groups loaded with 5 and 10 mL of conditioned media demonstrated significantly (p < 
0.5) greater detection of free amines over MPs loaded with 1 mL of media, * = Significant 
to SDS/heat treatment groups (p < 0.5); $ = Significant to untreated (-SDS/heat) 1 mL 














Retrieval of HMAm microparticles incorporated within embryoid bodies 
ESCs within EBs spontaneously differentiate during culture synthesizing a 
complex array of various factors and soluble cues that direct cell fate [153,154] 
Ultimately, GAG-based MPs could provide a tool to study morphogen production during 
ESC differentiation in order to advance understanding of how these components are 
modulated during early development. It was hypothesized that HMAm MPs incorporated 
within EBs could be used to develop a novel strategy to capture endogenously secreted 
ESC morphogens in a concentrated manner. After incorporation in EBs, HMAm MPs 
required separation from EBs without disruption of growth factor-heparin interactions. 
Generally, dissociation of EBs is performed by enzymatic digestion with trypsin. 
However, trypsin cleaves lysine and arginine amino acid residues, and would ultimately 
cleave MP bound protein. Therefore, a non-enzymatic digestion buffer was used to 
dissociate EBs and retrieve morhpogen-laden MPs (Figure 5.6A). MP bound protein was 
incubated with either trypsin or non-enzymatic dissociation buffer and then run on a gel 
to evaluate retention of protein (Figure 5.6B). MPs incubated in non-enzymatic 
dissociation buffer demonstrated more staining for protein as compared to MPs 
incubated in trypsin, indicating that non-enzymatic buffer limits protein dissociation from 
MPs.  
Percoll density gradient centrifugation was used to separate protein bound MPs 
from dissociated cells. After centrifugation, each of the three Percoll layers (top, 40.5%, 
and 58.5%) was aspirated into separate conical tubes and washed twice with PBS, 
followed by quantification of MP retrieval and separation from cells via flow cytometry 
(Figure 5.7). Each fraction was compared to control samples consisting of either single 




composed primarily of cells, with approximately 91.5% cells and 1.4% MPs, while the 










Figure 5.6. Non-enzymatic dissociation buffer treatment of EBs and CM- loaded 
MPs. A) Day 7 EBs were incubated at 37˚C with a non-enzymatic dissociation buffer to 
promote cell dissociation. Majority of EBs were dissociated by 15 minutes of incubation 
time. B) SDS-PAGE analysis was performed on conditioned media loaded MPs treated 
with either trypsin or non-enzymatic dissociation buffer. Trypsin treated MPs 
demonstrated a decrease in staining of protein as compared to untreated MPs and MPs 











Figure 5.7. Quantification of MP and cell separation by a Percoll gradient.  Percoll 
density gradient centrifugation was performed by layering a solution of MPs and cells on 
top of a 58.5 and 48.5 % layers in a 15 mL conical tube.  Approximately 91.5% cells 









Embryonic stem cells are a unique cell population that provide a readily 
accessible model system for early embryonic development. Harnessing the regenerative 
potential of ESCs will rely on understanding the complex system of signaling molecules 
that play an important role during self-renewal and differentiation. Ultimately, 
identification of endogenously secreted ESC factors will improve our understanding of 
the molecular mechanisms that govern cell fate.  Numerous attempts to characterize the 
secretome with MS has enabled the discovery of several proteins secreted by ESCs 
[161,174,177]. It has been well established that ESCs secrete key morphogenic factors 
that regulate cell lineage decisions and also bind directly to heparin, or act in complex 
with heparin and cell-surface receptors [63,68,86,183]. Heparin functionalized beads 
have been previously used to selectively bind morphogenic factors from ESC 
conditioned media in order to enrich for potentially therapeutic factors [184]. However, 
the identity and relative amounts of these factors has yet to be specifically elucidated. 
This study demonstrated the use of HMAm microparticles to bind and concentrate 
various biomolecules present in spent media collected from EBs undergoing 
differentiation.  
We hypothesized that MPs would capture specific heparin-binding growth factors 
(HBGFs), such as VEGF, FGF2, and BMP4 [148,179], and MS analysis could identify 
molecules bound to MPs. To investigate our hypothesis, we developed a method to 
concentrate molecules present in conditioned media. As demonstrated by the results, 5 
mL of conditioned media loaded on MPs can be analyzed via gel electrophoresis, while 
typically only 25-50 μL of conditioned media can be loaded in a gel.  Subsequently, 
characterization and analysis of MP bound protein was performed by gel 




demonstrated the ability of MPs to concentrate proteins in conditioned media with the 
surprising ability to also limit BSA binding. This is an important feature of our technique, 
as media contains high levels of BSA, which can mask the detection of lower abundance 
proteins, as evident in gels with conditioned media.. Growth factor and heparin binding is 
governed predominately by electrostatic interactions, with negatively charged heparin 
binding to positively charged growth factors [68,185]. It is hypothesized that proteins 
bind to heparin and other GAGs based on specific affinities to particular sequences 
present in the saccharide chain [85,186], suggesting that reduced BSA binding to MPs is 
due to decreased affinity for heparin. Furthermore, MPs of different polymer types (GMA, 
CSMA, HMAm, and Hep-PS) demonstrated differential binding of protein from 
conditioned media, , providing further evidence that different types of GAG-based MPs 
bind biomolecules with variable affinities. . Previous studies have demonstrated that 
GAGs of specific chain lengths and sulfation patterns can play diverse roles in regulating 
stem cell differentiation [80,87] . Therefore,  MPs composed of various ECM 
components such as GAGs could be utilized to direct ESCs toward specific lineages by 
enhancing certain signaling pathways based on their respective protein binding 
capacities.  
 MS analysis of proteins bound to MPs detected primarily intracellular proteins 
and little to no identification of HBGFs or other growth factors known to be present in 
ESC conditioned media [153,154,161] In typical LC-MS/MS approaches, only the most 
abundant proteins are often identified. Despite attempts to enrich for heparin-binding 
proteins in conditioned media using MPs prior to analysis, numerous low-abundance 
(<10-9 g/mL) proteins may remain undetected due to excess peptides from high 
abundance proteins present. In order to circumvent these limitations, iterative exclusion 
(IE) analysis can be employed [187,188]. Instead of performing a single repeat analysis, 




LC-MS/MS analysis followed by subsequent rounds of LC-MS/MS analysis, with the 
exclusion of peptides with mass/charge (m/z) values that match predicted tryptic 
peptides of proteins identified in previous rounds. IE-mass spectrometry approach has 
been shown to identify 10 times more previously undetected extracellular proteins, 
ranging in concentration from 10-9 to 10-11 g/mL [161]. Heparin can enhance signaling 
cascades that modulate cell proliferation, migration, and differentiation by binding, 
protecting, and presenting growth factors to cell receptors; however, the mechanisms 
that control cell behavior are poorly understood [148,189]. Retrieval of MPs from EBs via 
Percoll gradient provides a novel method to sequester ESC-secreted factors for 
analysis, not only to elucidate the role in which autocrine and paracrine factors play in 
self-renewal and differentiation of ESCs, but also for applications in regenerative 
therapies. Ultimately, identification of growth factors secreted/produced in differentiating 




Overall, HMAm MPs can be used as a tool to concentrate biomolecules present 
in ESC conditioned media, while simultaneously reducing presence of BSA for MS 
analysis. While MS analysis did not identify factors of interest, specifically HBGFs, 
improved IE-MS techniques can be employed to better identify peptides of lower 
abundance proteins. Ultimately, we aim to develop a new class of biomaterials capable 
of capturing and delivering stem cell derived morphogens in a biomimetic manner.  It is 
anticipated that the results of this work will provide new insights into the manner in which 







CONCLUSIONS AND FUTURE DIRECTIONS 
 
Embryonic stem cells provide a renewable cell population that possess the 
unique ability to differentiate into hundreds of cell types, providing a promising cell 
source for studies of early embryonic development and regenerative medicine 
applications. Harnessing the regenerative potential of ESCs will rely on improved 
directed differentiation approaches, as well as enhanced understanding of the complex 
system of signaling molecules that play an important role during self-renewal and 
differentiation. Differentiation of ESCs is traditionally performed in monolayer, allowing 
for uniform exposure of cells to exogenously biomolecules; however, 3D culture of ESCs 
provides a more biological model of embryogenesis by facilitating multicellular 
interactions [34]. Cellular organization and differentiation of an embryo can be modeled 
by the formation of pluripotent stem cell aggregates, known as embryoid bodies (EBs) 
[35]. EB formation has traditionally been used to induce spontaneous differentiation of 
ESCs towards the three germ lineages. Previous attempt to direct ESC differentiation 
have utilized an “outside-in” approaches via soluble growth factor or small molecule 
supplementation, to direct ESC differentiation are limited by non-homogenous 
differentiation of EBs [119]. Alternatively, EB differentiation can be controlled via the 
introduction of engineered microparticles (MPs) for delivery of growth factors 
[121,125,126] or via cell-material interactions [127]. Just as MP mediated growth factor 
delivery can enhance differentiation of ESCs toward defined cell types, endogenous 
growth factors produced by differentiating EBs can be harnessed by MPs to direct ESC 




with mass spectrometry (MS) analysis has enabled the discovery of several key proteins 
secreted by ESCs [161,174,177]. Additionally, it has been established that ESCs secrete 
key morphogenic factors that regulate cell lineage decisions and also bind directly to 
heparin or act in complex with heparin and cell-surface receptors [63,68,86,183]. 
Furthermore, heparin functionalized beads have been used to selectively bind 
morphogenic factors from ESC conditioned media in order to enrich for potentially 
therapeutic factors [184], however, the identity of ESC-secreted factors has yet to be 
fully elucidated.  
Synthetic N-isopropylmethacrylamide (NIPMAm) MP constructs were 
investigated as a biomaterial-based strategy to control the temporal release of BMP4 
within ESC aggregates to induce mesoderm differentiation. Synthesis of MPs produced 
well-coated population of MPs in terms of microgel coverage, a critical property for the 
uniform presentation of material and growth factors to cells, and low polydispersity, an 
important component to minimize variations in loading and release rates of growth 
factors. pNIPMAm MPs exhibited minimal aggregation during lyophilization and after 
incorporation, crucial for even distribution of MPs and uniform delivery of BMP4 within 
EBs. However, MPs incorporated with low efficiency within ESC aggregates, most likely 
due to lack of cell adhesive sites [127]. In future studies, increased MP incorporation 
could be achieved by adding Arg-Gly-Asp (RGD) or other cell adhesion sequences to 
microgels [146]. MP delivery of BMP4 within ESC aggregates demonstrated similar 
expression of mesoderm (Flk1) as compared to soluble BMP4 delivery, while ectoderm 
expression (Pax6) was significantly  decreased as compared to soluble delivery. In 
addition to analysis of gene expression, sentinel cells were used to monitor the spatial 
and temporal activation of BMP signaling in ESC aggregates, where maximum reported 
(CFP) expression was observed at day 2 of culture, coinciding with the burst release of 




BMP4 demonstrated higher expression of CFP over soluble BM4 treated aggregates, 
suggesting that unloaded MPs may bind and concentrate exogenously added or 
endogenously produced BMP4 within aggregates to induce BMP signaling. Notably, the 
total amount of BMP4 delivered by MP was 10-fold less total growth factor as compared 
to soluble delivery to achieve comparable ESC differentiation, indicating that MP 
approaches can improve efficiency of differentiation, by reducing soluble growth factor 
supplementation. 
The development of mature tissue and organs is governed by the coordinated 
action of multiple growth factors. One of the first reported dual delivery systems involved 
the release of PDGF encapsulated in PLGA microspheres embedded in a PLGA scaffold 
containing VEGF to improve blood vessel formation.[190] Different release kinetics were 
engineered to provide control over the temporal release of each growth factor. A study 
by Choi et al. achieved sequential release of BMP-2 and dexamethasone from a 
microcapsule comprised of a PLGA core and alginate shell [191]. pNIPMAm MPs 
provide a means to customize MPs with varied release kinetics to improve the 
differentiation of ESCs into defined cell populations by delaying or prolonging BMP4 (or 
other growth factors) presentation to ESCs. The size and charge of microgels can be 
tailored to control the loading and release of specific morphogens. Different formulations 
of microgels can be synthesized and mixed populations can be added to core particles 
for dual delivery of growth factors or small molecules for differentiation of ESCs toward 
defined cell types. For example, hematopoietic differentiation requires Wnt or Activin to 
for initial development of the hemangioblast followed by VEGF supplementation [28].    
In addition to electrostatic interactions between biomolecules, microgels with smaller 
mesh sizes can be used to imbibe small molecules (<900 Da) while larger mesh sizes 
can be fabricated to retain larger biomolecules (<15 kDa), such as growth factors. In 




responsive MPs that can improve the temporal control over morphogen delivery within 
ESC aggregates. Temporally controlled capture of ESC morphogenic factors could be 
performed by external control of thremoresponsive materials via temperature changes to 
enable the swelling or collapse of microgels, providing an additional level of control in 
the controlled d release of growth factors.  
Given the importance of heparin/HS for ESC differentiation, HMAm MPs provide a 
model to determine the ability of exogenous soluble GAG-based materials to influence 
patterns of differentiation within EBs.. Incorporation of HMAm MPs within EBs 
demonstrated the native ability of natural GAG-based materials to modulate ESC 
differentiation. Incorporation of HMAm MPs within ESC aggregates demonstrated 
changes in gene and protein expression of neuorectodermal marker, Pax6. Histological 
analysis of aggregates with incorporated HMAm MPs exhibited more  internal organized 
structures as compared to untreated aggregates. Despite various studies that have 
established a role for HS in ESC differentiation [76,86,151,192], one question that 
remains is whether additional fine structure requirements, such as sulfation, chain 
length, and concentration, exist for cell signaling pathways. A prerequisite to answering 
this question would be to establish how HS chainsbecome remodeled during  specific 
stages of development by examining expression for genes (EXT1/2, NDST1/2, etc 
involved in the biosynthesis of HS) and measuring total heparin content from 
differentiating ESCs by high performance liquid chromatography (HPLC) 
[72,76].Furthermore, the use of HS-deficient and HS-competent ESCs, have been 
previously used as in vitro models to determine the ability of exogenous GAGs to 
“rescue” differentiation and ESC signaling pathways [80,86,160]. For instance, EXT1-/- 
mESCs fail to differentiate into mesoderm, however partial restoration of FGF and BMP 
signaling was achieved by addition of soluble heparin [86]. Heparin/HS-deficient systems 




cell differentiation. Ultimately, a greater understanding of endogenous stem cell 
extracellular remodeling responses in response to various extracellular cues may enable 
rational approaches to initiating and mediating complex tissue morphogenic events. 
Engineering approaches for directing endogenous self-organization and remodeling 
responses of stem cells afford new opportunities for controlling of the complex signaling 
pathways regulating cell fate. 
It was also demonstrated that HMAm MPs can be used as a tool to sequester and 
concentrate biomolecules present in ESC conditioned media, while simultaneously 
reducing the amount of abundant species, such as BSA, for mass spectrometry analysis. 
Notably, MPs demonstrated approximately 20x less BSA binding, but improved staining 
for protein bands as compared to diluted conditioned media. Furthermore, GMA [118], 
CSMA [117,126], and HMAm [116] MPs exhibited different binding capacities for 
complex mixtures of proteins present in conditioned media, suggesting that MPs 
composed of different ECM components could be mixed to direct ESCs to specific 
lineages, similar to previous work that demonstrated that incorporation of MPs fabricated 
from PLGA, agarose, and gelatin induced different patterns of ESC differentiation [127]. 
Furthermore, fabrication of MPs composed of multiple ECM components, such as 
heparin (or HMAm) and chondroitin sulfate (or CSMA), could be fabricated to create 
synthetic ECM MPs. Previous work has demonstrated that heparin/HS sulfation patterns 
are critical in the recognization of soluble and matrix proteins [80,81,85,87,186,193], 
thus synthesis of HMAm MPs with varied sulfation patterns provides another means to 
regulate growth factor binding and modulate signaling activation.  
While GAGs and ECM proteins are important in regulating growth factor signaling, 
they interact with a wide array of growth factors with variable affinities and would likely 
impact a multitude of signaling pathways in parallel, which may ultimately limit the 




microspheres that incorporated a synthetic VEGF binding peptide derived from VEGF 
receptor 2 that demonstrates targeted binding of VEGF and release [90]. Engineering 
synthetic materials with ECM mimetic components could provide a means to increase or 
decrease specific signaling pathways by exploiting growth factor-material interactions 
and controlling the affinity and specificity with which MPs interact with stem cell 
produced growth factors. Ultimately, design of MPs that incorporate peptides that bind 
specific molecules would provide the ability to mimic the native ECM to regulate growth 
factor signaling that direct cell fate, but improve the specificity of materials for directed 
differentiation of ESCs .  While MS analysis did not identify heparin-binding growth 
factors previously detected in ESC conditioned media by ELISA [153,154], alternative 
MS techniques can be employed to identify peptides of lower abundance proteins. For 
instance, iterative exclusion (IE) analysis can be employed by analyzing protein fractions 
multiple times and excluding ions selected in the previous rounds [187]. In addition, 
directed differentiation approaches could be employed to study morphogen production 
during ESC differentiation and increase production of specific heparin-binding growth 
factors. For instance, hypoxic conditions further promote ESC differentiation by 
decreasing expression of pluripotency markers, while increasing expression of genes 
associated with vasculogenesis and angiogenesis, as well as increased VEGF 
production [11,49,194]. By increasing production of specific heparin-binding growth 
factors, HMAm MPs could be used to further improve differentiation as well as enable 
better identification of factors via MS analysis. Ultimately, development of biomaterials 
capable of capturing morphogenic factors in a ECM-mimetic manner introduces a novel 
approach to direct differentiation of ESCs and demonstrates the utility of GAG MPS as a 
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